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CHAPTER 1

INTRODUCTION
In order for essential processes such as DNA replication, repair, recombination, and
gene expression to occur, chromatin must be accessible to regulatory proteins and
transcriptional machinery. The regulation of chromatin accessibility is two-fold: i) Nterminal histone tail modifications allow for recruitment of regulatory proteins; ii) energydependent multimeric complexes catalyze alterations in the physical contacts between DNA
and histones. With the recent identification of histone lysine demethylase enzymes, a new
exciting question arose: Is there a functional relationship between these epigenetic
modifying enzymes and chromatin remodeling complexes?
The most widely studied ATP-dependent chromatin remodeling complex is the
evolutionarily conserved SWI/SNF (mating type switch/sucrose nonfermenting) complex.
The Dingwall lab uses a Drosophila melanogaster model system to study SNR1, a regulatory
subunit known to restrict complex activity during wing patterning and development. An
antimorphic temperature-sensitive mutant allele (snr1E1) leads to target gene misregulation
and formation of extra wing vein material. Using a candidate genetic screen to identify
dominant modifiers of the snr1E1 phenotype, I found that loss of function mutations in lysine
demethylase enzymes genetically interact with snr1E1, suggesting functional
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cooperation between chromatin remodeling complexes and demethylating enzymes in
regulating gene expression.

My project has focussed on characterizing how one particular demethylase
enzyme, Lysine Specifc Demethylase-1 (dLSD1) contributes to cell-fate choices made
duing the course of wing development. My data suggests that dLSD1 cooperates with the
Brm complex to regulate the highly conserved TGFβ (Dpp) signaling pathway

Chapter 2
Literature Review
2.1 Chromatin and epigenetic modifiers
In the eukaryotic cell, DNA is organized into a higher-order structure known as
chromatin. DNA associates with an octameric complex of histone proteins to form
nucleosomes. The histone octamer contains a central (H3-H4)2 tetramer flanked by two
H2A-H2B dimers. Approximately 146 bp of DNA is wrapped around the histone octamer
(Luger, Mader et al. 1997). Chromatin can exist in a compact (heterochromatin) or
relaxed (euchromatin) form and several factors contribute to chromatin status. Essential
cellular processes, such a DNA replication, DNA repair, viral integration, gene
transcription, and malignant transformation, are dependent upon chromatin status
(Klochendler-Yeivin, Muchardt et al. 2002; Martens and Winston 2003; Pumfery, Deng
et al. 2003; Groth, Rocha et al. 2007). Chromatin organization is a fundamental
constraint involved in regulating the expression of eukaryotic genes, since the presence of
a nucleosome around a binding site blocks the accessibility of most transcriptional factors
to the cognate binding sequences (Martens and Winston 2003).
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There are two main types of factors that contribute to chromatin status: (1)
ATP-dependent chromatin remodeling complexes utilize the energy of ATP-hydrolysis to
physically tighten or loosen histone-DNA contacts and (2) epigenetic modifying enzymes
add or remove covalent modifications from histone tails, hence influencing the DNAhistone binding (Workman and Kingston 1998; Saha, Wittmeyer et al. 2006). ATPdependent chromatin remodeling complexes regulate the expression of many genes by
reorganizing chromatin structure in response to regulatory signaling, thus enabling the
binding of transcription factors and accessory activator or repressor complexes to
regulatory sequences of target genes (Li, Carey et al. 2007). Remodeling complexes can
relax histone-DNA contacts by either causing the DNA (>20bp) to “bulge” out from the
histone octamer, or by causing the nucleosome to slide along the DNA, thus allowing
transcriptional machinery access to regulatory regions within the DNA sequence
(Hamiche, Sandaltzopoulos et al. 1999; Whitehouse, Flaus et al. 1999; Schnitzler,
Cheung et al. 2001; Saha, Wittmeyer et al. 2005; Shundrovsky, Smith et al. 2006; Zhang,
Smith et al. 2006). These remodeling complexes also have a role during cellular division,
as they are essential for displacing and replacing histone complexes during mitosis
(Sawa, Kouike et al. 2000). Chromatin remodeling complexes work in conjunction with
epigenetic modifying enzymes to regulate chromatin status. Several histone proteins
(primarily H3 and H4) can be phosphorylated, acetylated, methylated, or sumoylated on
the N-terminal portion, known as “histone tails.” Histone proteins can also be
ubiquitinated on the C-terminal tails. These tails extend away from the nucleosome, and
are exposed to enzymes that add or remove covalent modifications. Certain

5
combinations of histone-tail modifications have been associated with either gene
repression or gene activation. This is known as the “histone code” (Turner 1993; Strahl
and Allis 2000; Jenuwein and Allis 2001; Turner 2002). Specific modifications, such as
lysine acetylation, are typically associated with gene activation. Other modifications,
such as methylation, can be associated with either gene repression or gene activation,
depending on which residue of the histone tail is modified, location within the gene
(promoter vs. coding regions), as well as degree of methylation (mono-, di-, or trimethylation). Modifying enzymes in the nucleus add or remove histone tail
modifications. The contribution of chromatin remodeling complexes and epigenetic
modifiers to gene regulation has been studied extensively (Peterson and Laniel 2004).

2.2 ATP-dependent chromatin remodeling complexes
ATP-dependent chromatin remodeling complexes are made up of multiple subunits. All
complexes only contain 1 ATPase subunit. Other subunits likely function to regulate
complex activities, through protein-protein interactions, or for recruitment to specifc gene
regions. All ATP-dependent chromatin remodeling enzymes are members of the helicase
superfamily 2 (SF2). Chromatin remodeling complexes are subdivided into three main
groups: Swi (Switching-deficient)/ Snf (Sucrose Non-Fermenting), imitation SWI
(ISWI), and the Mi-2/Nucleosome remodeling factor (NuRF) group, based on structural
characteristics of the single ATPase subunit (Eisen, Sweder et al. 1995).
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2.2.1 Imitation-Switch (ISWI) remodeling complexes
The ISWI family of remodeling complexes has three members, all of which contain the
ISWI ATPase subunit. The NuRF complex has four subunits (ISWI, NURF301,
NURF55, NURF38) as does the CHRAC (chromatin accessibility complex) complex
(CHRAC14, CHRAC16, ACF, and ISWI). The ACF (ATP-utilizing chromatin assembly
and remodeling factor) complex contains only two subunits (ISWI and ACF) (Tsukiyama
and Wu 1995; Ito, Bulger et al. 1997; Varga-Weisz, Wilm et al. 1997). ISWI
remodeling complexes have an important role in maintaining chromosomal integrity,
since Drosophila iswi null mutants die during late larval development and have a
“puffed,” decondensed male X chromosome (Deuring, Fanti et al. 2000). ACF1
functions in either establishment or maintenance of transcriptional silencing. The
complexes are important in cell cycle progression and gene transcription, since acf1 null
mutants have accelerated entry into S phase. (Fyodorov, Blower et al. 2004). ISWI
complexes have an important role in regulating genes involved in Ecdysone signaling in
Drosophila (Badenhorst, Xiao et al. 2005). ISWI family members regulate chromatin on
a global as well as gene specific level.

2.2.2 The Brahma chromatin remodeling complex
The most widely studied, evolutionarily conserved chromatin remodeling complex is a
member of the Swi/Snf family, and is known as the Brahma (Brm) complex in
Drosophila. SWI/SNF complexes play critical roles in DNA replication and repair, RNA
Polymerase II transcription, as well as metazoan embryonic development and postnatal
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tissue regeneration through regulating cell proliferation, differentiation and survival.
The yeast and metazoan SWI/SNF complexes are composed of 8-11 unique subunits with
an approximate molecular mass of 1.2 MDa (Peterson, Dingwall et al. 1994; Smith,
Horowitz-Scherer et al. 2003). The complex has a single ATPase subunit that is required
both in vitro and in vivo for ATP-dependent chromatin remodeling activity. However, full
in vitro chromatin remodeling activity on mono-nucleosomes and nucleosomal arrays can
be achieved with reconstitution of 4 mammalian “core” subunits, BRG1, INI1/BAF47,
BAF170, and BAF155 (Phelan, Sif et al. 1999), making it likely that the remaining
subunits are important for complex stability, regulation, and/or targeting.
The Drosophila SWI/SNF counterpart is known as the Brahma (Brm) complex
and can be divided into two subclasses. The chromatin remodeling activities of the Brm
complex are important for both the activation and repression of gene transcription during
development (Simon and Tamkun 2002). The BRM protein co-localizes with RNA
Polymerase II on salivary gland polytene chromosomes within regions undergoing active
gene transcription (Armstrong, Papoulas et al. 2002; Zraly, Marenda et al. 2003).
Microarray analyses of Brm complex mutants demonstrated that the complex was likely
involved in both transcription activation and repression (Zraly, Middleton et al. 2006).
The role of Brm complex regulation during gene activation has been extensively
characterized and often involves recruitment of histone modifying enzymes, such as
histone acetyltransferases (HATs), and gene specific transcription factors (Kingston,
Bunker et al. 1996; Simon and Tamkun 2002). Less well defined is the role of the Brm
complex in gene repression. Several complex components contain DNA binding motifs
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and/or domains that recognize and bind to specific histone tail modifications
(Mohrmann and Verrijzer 2005), but recruitment of the complex to specific gene
regulatory regions is highly dependent on complex association with other factors, such as
transcription factors and histone tail modifying enzymes.
The SWI/SNF family of remodeling complexes can be divided into two
subclasses that have the same constellation of core subunits, with differences in signature
subunit composition (Mohrmann and Verrijzer 2005). In Drosophila, BAP complexes
contain OSA as a signature subunit while PBAP complexes contain
POLYBROMO/BAP180, BAP170 and SAYP but not OSA (Collins and Treisman 2000;
Mohrmann, Langenberg et al. 2004; Moshkin, Mohrmann et al. 2007; Chalkley, Moshkin
et al. 2008) These complexes appear to regulate different targets, and will be described
later.
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Figure 1: Brahma complex subunit composition

Figure 1: Schematic demonstration of the domain architecture of Brm complex
subunits. BROMO: binds acetylated lysines; LXXLL (L=Leucine, X= any amino acid):
nuclear hormone binding; ARID: binds AT-rich DNA; BAH: Bromo adjacent homology
domain, SWIRM (for Swi3, Rsc8 and Moira) protein-protein interactions, SANT (Swi3Ada2-NCoR-TFIIIB): myb-like DNA binding domain;

HMG BOX: binds non-B-type

DNA conformations; Zn (Zinc finger): DNA binding; SWIB (SWIB/MDM2): proteinprotein interactions; R1/R2 (Repeat region 1/2): protein-protein interactions; CC (Coiledcoil): protein-protein interactions. This figure was adapted from (L. Mohrmann and P.
Verrijzer (2005) Biochim Biophys Acta 1681, 59-73). Domain predictions were derived
from analyses using the SMART-tool (http://www.smart.emblheidelberg.de/
smart/showmotifs.pl).
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The BRM protein has two known domains, an ATPase domain essential for
chromatin remodeling activites, as well as a bromodomain, which recognizes and binds
acetylated lysine in the histone tail. SNR1 is a 370 amino acid protein which includes
two imperfect repeat regions, (R1 and R2) and a coiled-coil (CC) motif. The MOR
protein consists of 1209 amino acids and three known domains, the SWIRM domain,
SANT (Swi3-Ada2-NCoR-TFIIIB) domain, and leucine zipper. It has been proposed that
the core components BRM, MOR, and SNR1 are held together by the physical contacts
made between MOR-BRM and MOR-SNR1 (Moshkin, Mohrmann et al. 2007). A 2hybrid library screen studying Drosophila protein interactions provided supporting
evidence that SNR1 directly associates with MOR (http://pim.hybrigenics.com/
pimriderext /common/). In these studies, a full length SNR1 bait fusion construct was
tested for interaction with various overlapping prey constructs. Among all prey fusion
constructs tested, the strongest to interact with SNR1 was MOR. A small prey fusion
construct containing a portion of the MOR SWIRM domain was able to physically
interact with the full length SNR1 bait fusion construct. In the study described here, I
sought to more closely examine how SNR1 and MOR contribute to chromatin
remodeling activities by studying their genetic and physical interactions.
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2.1.4 SWIRM domains
SWIRM domains have been identified in three different proteins, SWI3, LSD1, and
Ada2a. The crystal structure of each has been solved (Ogata, Morikawa et al. 1994;
Tochio, Umehara et al. 2006; Schuetz, Bernstein et al. 2007). SWI3, the yeast MOR
homolog, is a subunit is all SWI/SNF chromatin remodeling complexes. LSD1, as
described above, is a histone lysine demethylase enzyme. Ada2a is a transcription
factor. SWIRM domains are composed of one long central alpha-helix surrounded by 3-5
shorter alpha-helices. The loops connecting helices are well ordered and highly
conserved. Two potential solvent exposed patches for protein-protein interactions to
occur are present on opposite sides of the domain. These binding pockets are formed by
the solvent exposed loops. The loop regions I, III, and V compose one binding pocket,
whereas loops II and IV form the other (Qian, Zhang et al. 2005). The SWIRM domain
has an important role in mediating protein-protein interactions. The N-terminal portion
of the SRG3 SWIRM (the mouse homolog of MOR), for example, is important for the
binding of another complex component, BAF60, whereas the C-terminal portion of the
SWIRM domain, especially the last six amino acids, were essential to bind SNF5/Ini1
(the mammalian homolog of SNR1) (Sohn, Lee et al. 2007). The SWIRM domain of
human Ada2a and SMARCC2 is also capable of binding DNA (Qian, Zhang et al. 2005).
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2.3 Histone Methylation and Demethylation
As mentioned earlier, covalent histone tail modifications are important for regulating the
accessibility of other proteins like transcription factors to DNA. The arginine and lysine
residues can be methylated within the histone tails (Murray 1964; Gershey, Haslett et al.
1969; Patterson and Davies 1969). (Figure 2) Arginine residues can be mono- and
dimethylated, whereas lysine residues can be mono-, di-, and trimethylated (Shilatifard
2006). Three groups of methyltransferases have been identified. The SET domaincontaining proteins (named after three proteins it was first characterized in, Su(var)3-9,
Enhancer of Zeste, and Trithorax), can methylate histone 3 (H3) lysine residues 4, 9, 27,
and 36 (H3K4, H3K9, H3K27, and H3K36) histone 4 (H4) lysine 20 (H4K20). Non-SET
domain containing proteins, such as Dot1L, methylate H3K79 (Jones, Su et al. 2008).
Arginine methyltransferases (PRMTs) can methylate H3 arginine residues 2, 17, and 26
(H3R2, H3R17, H3R26), and H4R3 (Shilatifard 2006). Arginine methylation has been
associatied with both gene activation and gene repression (Kouzarides 2007). Specific
histone lysine methylation has been associated with either gene activation or repression.
Methylation of H3K4, H3K36, and H3K79 are associated with gene transcription (Gerber
and Shilatifard 2003; Hampsey and Reinberg 2003; Krogan, Dover et al. 2003; Krogan,
Kim et al. 2003), whereas methylation of H3K9, H3K27, and H4K20 are associated with
gene repression (Brumby, Zraly et al. 2002; Ng, Feng et al. 2002; van Leeuwen, Gafken
et al. 2002; Plath, Fang et al. 2003).
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It was thought that methylation of lysine residues on histone tails was a
permanent mark due to the high thermodynamic stability of the N-CH3 bond. The
enzymes that add methyl marks (methyltransferases) are well described, but the
identification of histone lysine demethylase enzymes did not occur until more recently
(Shi, Lan et al. 2004). Initial observations of potential histone lysine demethylase
enzymes were made over forty years ago when an amine-oxidase reaction that generated
non-methylated lysine residues and formaldehyde as byproducts was observed in tissue
extracts (Kim, Benoiton et al. 1964). A similar predicted enzymatic activity was later
observed when histones were used as the substrate (Paik and Kim 1973; Paik and Kim
1974). The first histone demethylase enzyme, Lysine Specific Demethylase-1 (LSD1)
was identified and characterized more than 30 years later (Shi, Lan et al. 2004).

2.3.1 Lysine Specific Demethylase-1 (LSD1)
Two classes of histone demethylase enzymes have been identified, the Lysine Specific
Demethlyase-1 (LSD1) family and the Jumonji family (JmjC-domain containing) (Shi,
Lan et al. 2004; Forneris, Binda et al. 2005; Tsukada, Fang et al. 2006; Whetstine, Nottke
et al. 2006). LSD1 is a flavin adenine dinucleotide (FAD)-dependent amine oxidase that
utilizes an oxidative process to demethylate its substrates (Forneris, Binda et al. 2005). It
has three domains, a SWIRM domain, likely important for protein-protein interactions, an
Amine Oxidase domain, responsible for demethylase activity (Shi, Lan et al. 2004), and
the Tower Domain, which has been shown to bind the accessory protein, CoREST (CoRE1 silencing Transcription Factor) (Yang, Gocke et al. 2006). Formaldehyde is
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produced as a byproduct of the demethylation reaction and can be measured
experimentally as a read out of demethylase activity (Shi, Lan et al. 2004). LSD1
catalyzes the removal of mono- and dimethylated lysine 4 on histone tail 3 (H3K4) (Shi,
Lan et al. 2004; Forneris, Binda et al. 2005). In mammals, when associated with the
Androgen Receptor (AR) or Estrogen Receptor (ER), LSD1 can demethylate mono- and
di-methylated lysine 9 (H3K9) (Metzger, Wissmann et al. 2005; Garcia-Bassets, Kwon et
al. 2007).
H3K4 methylation is associated with gene activation, whereas H3K9 methylation
is generally associated with gene repression (Shilatifard 2006). LSD1 has a role in gene
repression by demethylating H3K4 methylated substrates. However, in complex with the
AR or ER it demethylates H3K9, demonstrating that it has a role in gene activation
(Metzger, Wissmann et al. 2005). LSD1 appears to regulate a different set of genes
when in complex with the AR/ER and (Metzger, Wissmann et al. 2005) is discussed in
Section 2.4.
LSD1 demethylase activity is limited to mono- and dimethylated lysine
substrates, due to the inherent nature of the reaction, in that a protonated nitrogen is
required to initiate the demethylation reaction (Shi, Lan et al. 2004) (Figure 2). LSD1
can also demethylate dimethylated lysine residues of non-histone substrates, including
p53. Demethylation prevents binding of 53BP1 and blocks p53 activity, indicating an
important role for LSD1 in cell cycle control (Huang, Sengupta et al. 2007).
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Figure 2: Mechanisms of demethylation

Figure 2: LSD1 and Jumonji family demethylases utilize different enymatic
reactions to demethylate lysine substrates. LSD1 requires a protonated nitrogen to
form the imine intermediate, therefore limiting substrate specificity to dimethlyated and
monomethylated substrates. The Jumonji family of demethylases can demethylated
trimethylated lysine substrates, since the mechanism does not require a protonated
nitrogen. This figure was adapted from (Anand and Marmorstein 2007)
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2.3.2 Jumonji family demethylases
The much larger Jumonji family of histone lysine demethylases utilize a FeII++
and alpha-ketoglutarate dependent mechanism (Figure 2). Jumonji demethylases can
demethylate a much broader spectrum of lysine substrates, including mono-, di-, and
trimethylated lysine residues (Cloos, Christensen et al. 2006; Klose, Yamane et al. 2006;
Tsukada, Fang et al. 2006; Whetstine, Nottke et al. 2006; Yamane, Toumazou et al.
2006). The Jumonji demethylases characterized so far appear to favor demethylatation of
trimethylated lysines, though they are capable of removing dimethyl and monomethyl
modifications as well (Couture, Collazo et al. 2007; Ng, Kavanagh et al. 2007). Several
demethylases also have dual substrate specificity. For example, JHDM1/KDM7 is
capable of demethylating dimethylated H3K9 as well as dimethylated H3K27, both
marks associated with active gene transcription (Tsukada, Ishitani et al.; Cloos,
Christensen et al. 2006; Klose, Yamane et al. 2006; Whetstine, Nottke et al. 2006; Klose
and Zhang 2007).

The catalytic core of the protein is located within the Jumonji-C

(JmjC) domain (Tsukada, Fang et al. 2006). The Jumonji enzymes can also demethylate
histone arginine residues (Chang, Chen et al. 2007).
There are 27 JmjC domain containing proteins in the human genome, which can
be divided into 3 subfamilies based on homology in the JmjC domain (Cloos, Christensen
et al. 2008). These groups uniquely demethylate specific substrates. The UTX/JMJD3
group demethylates H3K27 me1/me2/me3 (Jepsen, Solum et al. 2007) (Agger, Cloos et
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al. 2007; De Santa, Totaro et al. 2007; Lan, Bayliss et al. 2007; Lee, Villa et al. 2007),
the H3K4 me2/me3-specific JARID1 group (Iwase, Januma et al. 2004; Christensen,
Agger et al. 2007; Klose and Zhang 2007; Lee, Villa et al. 2007; Tahiliani, Mei et al.
2007), and the JMJD1 group, which has specificity for H3K9me1/me2 (Yamane,
Toumazou et al. 2006).
Jumonji family proteins are so named because the first characterized JmjCdomain containing mutant mice (JARID2) displayed an abnormally developed neural
plate, resembling the shape of a cross (Takeuchi, Yamazaki et al. 1995). The word
Jumonji means cruciform in Japanese. JmjC family enzymes are often found in
multiprotein complexes that can include HDACs, histone methyltransferases (HMTs),
nuclear receptors, transcriptional repressors (ex. N-CoR) and/or polycomb group proteins
(Ahmed, Palermo et al. 2004; Gray, Iglesias et al. 2005; Yamane, Toumazou et al. 2006;
Agger, Cloos et al. 2007; Garcia-Bassets, Kwon et al. 2007; Klose and Zhang 2007;
Tahiliani, Mei et al. 2007; Wissmann, Yin et al. 2007; Wolf, Patchev et al. 2007; Pasini,
Bracken et al. 2008).
In mammals, some JmjC family members have a role in maintaining self-renewal
since RNAi depletion of JMJD1a or JMJD2c leads to differentiation in cultured mouse
embryonic stem cells (Loh, Zhang et al. 2007). Other JmjC family members have a role
in HOX gene regulation (Agger, Cloos et al. 2007). JmjC enzymes have also been
implicated in regulating cellular senescence, in part by regulating H3K27 trimethylation
of the INK4a-ARF locus. This locus is a sensor of cellular senescence and loss of INK4a-
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ARF expression is strongly correlated with oncogenesis (Bracken, Kleine-Kohlbrecher
et al. 2007). The JMJD3 demethylase gene is located in close proximity to tumor
suppressor gene p53 and is frequently lost in genetic lesions associated with oncogenesis,
leading to a more aggressive cancer (Nigro, Baker et al. 1989). Demethylase enzymes
are likely important for X-chromosome inactivation, since one of the initial steps of
inactivation is loss of covalent H3K4me2/me3 from histone tails and the addition of
H3K9 methylation within the X-inactivation center (Heard 2005).
A high degree of functional redundancy likely exists among demethylases in
mammals (Klose and Zhang 2007). Null mutation of the only JARID1 family orthologs
in Drosophila (lid) and C. elegans (rbr-2) leads to lethality in flies and severe
developmental defects in worms (Christensen, Agger et al. 2007; Secombe, Li et al.
2007). Mammals express four different JARID1 orthologs (Cloos, Christensen et al.
2008). Jarid1a-null mice appear to develop normally, though some behavioral
phenotypes and neutrophilia (increased neutrophils in circulation) were observed,
indicating that the activity of other JARID1 familiy demethylase enzymes likely rescues
some but not all developmental phenotypes (Klose, Yan et al. 2007).
2.4 LSD1 has an essential role in mammalian development
LSD1 is highly conserved from yeast (S. pombe but not S. cerevisiae) to humans (Shi,
Lan et al. 2004). LSD1 was first characterized as a protein important for gene repression
based on knockdown experiments in cell culture analyses where loss of LSD1 led to
derepression of neuron-specific genes, in non-neuronal cells (Shi, Lan et al. 2004). LSD1
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functions to repress neuron specific genes (ex. Nicotinic Acetylcholine Receptor β
(nAcrβ), Na channel (Nach) )in both human and metazoans (Shi, Lan et al. 2004; Di
Stefano, Ji et al. 2007), demonstrating LSD1 function is evolutionarily conserved.
Knockdown of LSD1 in mice is lethal. To understand the significance of LSD1
in development, LSD1 conditional knockout mice were generated that specifically
remove LSD1 from the developing anterior pituitary gland (Wang, Scully et al. 2007). In
mice, the anterior pituitary gland is an excellent model to understand how LSD1 can
contribute to cell-type specific gene activation/gene repression during organogenesis.
Morphologically, the pituitary glands in LSD1 conditional knockouts appear to develop
normally. However, pituitary function is altered so that expression of pituitary-specific
hormones is significantly decreased. Because early pituitary development is normal in
these animals, LSD1 seems to be important in late cell-lineage as well as terminal
differentiation events. Increasing evidence suggests that the determinant of LSD1
activity and specificity is based on its physical association with other proteins, as well as
covalent modifications of residues nearby H3K4 (Forneris, Binda et al. 2005; Lee,
Wynder et al. 2005; Metzger, Wissmann et al. 2005; Shi, Matson et al. 2005; Forneris,
Binda et al. 2006). Chromatin immunopreciptitation experiments demonstrate that the
LSD1/ C-terminal Binding Protein (CtBP)/CoREST complex binds on specific promoter
regions (Wang, Scully et al. 2007). LSD1 is responsible for stabilizing the corepressor
complex on chromatin and it may serve to dock the CoREST repressor complex
(Forneris, Binda et al. 2005). Conditional LSD1 knockout prevents recruitment of the
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complex to these promoters and consequently results in increased dimethylated H3K4.
Moreover, LSD1 may play a role in CtBP-mediated repression of Notch signaling, since
downstream Notch targets were increased upon loss of LSD1 in these conditional
knockouts (Wang, Scully et al. 2007).
2.5 dLSD1 has an important role in Drosophila development
LSD1 is non-essential in flies, although lsd1 null animals have decreased adult
viability and are sterile due to defects in ovary development and decreased
spermatogenesis. Homozygous null animals are unable to fly, likely due to the associated
held-out wing phenotype (Di Stefano, Ji et al. 2007). The affect of LSD1 loss
(homozygous null animals) on specific target gene regulation is minimal in embryos and
larvae, but significant in pupae. This suggests that LSD1 may have an important role in
regulating gene transcription during later developmental stages. Hox genes are known
targets of LSD1, though lsd1 mutants do not have homeotic mutant phenotypes. No
global changes in H3K9 methylation were observed in homozygous null flies (Di
Stefano, Ji et al. 2007). However, LSD1 may regulate different genes in different tissues
and this may depend on the physical associations made between LSD1 and other
coregulatory proteins. Such an effect was observed in mammalian systems where LSD1
can demethylate H3K9 when in complex with the AR and ER (Metzger, Wissmann et al.
2005; Garcia-Bassets, Kwon et al. 2007).
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2.6 hLSD1 demethylation is dependant upon association with two cofactors,
CoREST and BHC80
Human LSD1 (hLSD1) has been studied in vitro and in vivo. hLSD1 activity is
regulated by association with its cofactors (Lee, Wynder et al. 2005; Metzger, Wissmann
et al. 2005; Shi, Matson et al. 2005) and has been identified in corepressor complexes that
include other known repressive cofactors, such as Co-RE1 Silencing Transcription Factor
(CoREST), CtBP and HDACs (Ballas, Battaglioli et al. 2001; Battaglioli, Andres et al.
2002; Hakimi, Bochar et al. 2002; Lunyak, Burgess et al. 2002; Hakimi, Dong et al.
2003; Shi, Sawada et al. 2003).
Two coregulatory proteins have been shown to directly associate with LSD1,
CoREST and BHC80, and both have an important role in regulating LSD1 demethylase
activity (Hakimi, Bochar et al. 2002; Iwase, Januma et al. 2004; Shi, Matson et al. 2005).
CoREST increases hLSD1 activity, while BHC80 decreases the activity in vitro (Shi,
Matson et al. 2005). Other than controlling the ability of LSD1 to demethylate lysine
substrate, CoREST has an additional role in hLSD1-mediated gene regulation. It protects
hLSD1 from proteosomal degradation and CoREST enhances LSD1 binding to
nucleosomes (Lee, Wynder et al. 2005; Shi, Matson et al. 2005).
CoREST contains two SANT domains (for Switching-Defective protein 3 (Swi3),
Adaptor 2 (Ada2), NuclearReceptor Co-repressor (NCoR), Transcription Factor II B
(TFIIB)). The N-terminal-most CoREST SANT domain is essential for HDAC1
association and subsequent target gene suppression (You, Tong et al. 2001). The SANT
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domains present histone tails in the appropriate conformation so the enzymes
responsible for adding/removing covalent modifications can recognize, bind, and modify
appropriate residues in the catalytic site (Boyer, Langer et al. 2002). The CoREST
SANT functions as a bridging domain to present methylated H3K4 histone tails to LSD1,
allowing for the demethylase reaction to occur (Shi, Matson et al. 2005). Moreover, the
CoREST SANT domain binds DNA in a non-sequence specific manner and this binding
is essential for LSD1-mediated demethylation (Yang, Gocke et al. 2006). By studying
the LSD1- BHC80 relationship, a significant observation was made when it was
discovered that non-methylated lysine substrates (H3K4me0) are also an integral part of
the histone code hypothesis. The PHD finger of BHC80 binds unmethylated H3K4, an
interaction that is blocked by H3K4 methylation. BHC80 and LSD1 depend on each
other reciprocally for binding to chromatin, as shown by ChIP experiments. Knockdown
of BHC80 by RNAi lead to derepression of LSD1 target genes (Shi, Matson et al. 2005).
Furthermore, the demethylation reaction by LSD1/CoREST is impeded by
hyperacetylation and accelerated by hypoacetylation of nearby lysine residues, indicating
that other factors in complex with LSD1, even if not in direct contact, affect demethylase
activity (Shi, Matson et al. 2005). This evidence suggests that histone demethylation and
deacetylation are functionally coupled.
2.7 hLSD1 can associate with multiple multi-subunit protein complexes
During transcriptional regulation, the activities of chromatin remodeling
complexes and epigenetic modifiers are highly dependent upon each other. The
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relationship between histone demethylase enzymes and chromatin remodeling
complexes is not yet well understood. hLSD1 has been detected in several large multiprotein supercomplexes including the transcriptional regulator ALL-1 (Nakamura, Mori
et al. 2002), and remodeling complexes, such as Mi-2/NuRD and Brg1.
The role of LSD1 in target gene regulation likely depends on the other proteins it
physically associates with. For example, a corepressor complex composed of the BRG1
complex, REST, mSin3A, and CoREST was observed in human nonsmall cell lung
carcinoma lines (Watanabe, Mizutani et al. 2006). Physical associations have also been
observed between the LSD1 cofactor protein, hCoREST, and the BAF57 subunit of the
Brg1 complex (Battaglioli, Andres et al. 2002), further suggesting an important
relationship between LSD1/CoRESTand SWI/SNF remodeling complexes. Here, the
activities of LSD1 corepressor components and chromatin remodeling activity appear to
be depedent on each other. Brg1 remodeling activities are essential for proper targeting
of the larger LSD1/CoREST, REST (Repressor Element 1-Silencing Transcription
Factor), Brg1 complex to appropriate promoter sequences and subsequent regulation of
target genes (Ooi, Belyaev et al. 2006). Since the Brg1 complex has no DNA-targeting
module to drive recruitment to specific target genes, it is likely that Brg1 remodeling
activities occur subsequent to LSD1 corepressor activity, allowing access for REST to
recognize, bind, and recruit the larger Brg1/LSD1 supercomplex to specific target genes.
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2.8 dLSD1 can exist in large-multiprotein complexes
In Drosophila, immunoprecipitation experiments suggest a complex forms between the
HDAC1/2 class protein RPD3, LSD1, CoREST, and two TRAMTRACK splice variants
Tramtrack88 (Ttk88) and/or Tramtrack69 (TTK69) (Dallman, Allopenna et al. 2004).
(Figure 3) TTK and REST are functional homologs. Orthologs of TRAMTRACK only
exist in invertebrates, whereas orthologs of REST only exist in vertebrates (Dallman,
Allopenna et al. 2004). Both proteins have the same function, to recognize and bind RE1 consensus sequences. tramtrack undergoes alternative splicing leading to two
isoforms, ttk69 and ttk88 (Xiong and Montell 1993). TTK69 can physically bind to
NuRD remodeling and CtBP corepressor complexes (Wen, Nguyen et al. 2000;
Murawsky, Brehm et al. 2001). TTK88/TTK69 heterodimers exist (Badenhorst, Finch et
al. 2002), although complete overlap was not observed on polytene chromosomes
(Dallman, Allopenna et al. 2004), suggesting they may exist independently or in unique
complexes.

CoREST, TTK69, and TTK88 all localize to polytene chromosomes.

However, CoREST and TTK69 colocalize on approximately half of polytene binding
sites, whereas most TTK88 binding sites were also bound with CoREST (Dallman,
Allopenna et al. 2004). A complex can also form between the methyltransferase
Suppressor of variegation 3-9 (Su(var)3-9), Rpd3, the heterochromatin promoting factor
Heterochromatin Protein 1 (HP1), and dLSD1. These factors work in conjunction to
regulate gene repression and heterochromatin formation (Rudolph, Yonezawa et al.
2007). LSD1 suppresses position-effect variegation (PEV) in both S. pombe and
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Drosophila (Di Stefano, Ji et al. 2007; Rudolph, Yonezawa et al. 2007), suggesting
that loss of LSD1 affects heterochromatin homeostasis. The order these enzymes
epigenetically modify histone tail residues has been described. First, LSD1 facilitates
removal of methyl groups from H3K4. This is followed by the addition of methyl groups
to H3K9 by Su(var)3-9 (Rudolph, Yonezawa et al. 2007). This is important because both
loss of H3K4 methylation and gain of H3K9 methylation are associated with gene
repression, demonstrating that the combined efforts of multiple enzymes are important
for gene regulation.

2.9 Transcription factors Tramtrack69 and Tramtrack88
Tramtrack69 (Ttk69, for 69 kDa) and Tramtack88 (Ttk88, for 88 kDa) arise from
alternative splicing of the tramtrack gene. The first 286 amino-terminal residues of
Ttk69 and Ttk88 are identical, but each has unique carboxy-terminal pairs of C2H2-type
zinc finger motifs as well as 3’ regulatory regions (Figure 3) (Xiong and Montell 1993).
Zinc finger motifs are required for sequence-specific DNA binding, suggesting that Ttk69
and Ttk88 may regulate different genes (Read and Manley 1992). Tramtrack69 was first
identified as a negative transcriptional regulator bound to regulatory regions of evenskipped (eve) and fushi tarazu (ftz), genes important for proper body segmentation during
embryogenesis (Harrison and Travers 1990; Brown, Sonoda et al. 1991; Read and
Manley 1992). Ttk88 physically associates with regulatory regions of engrailed (en),
another important segment polarity gene, though it appears to have a lesser role in
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embryogenesis, since overexpression of ttk88 led to no apparent segmentation defects
(Read and Manley 1992). Characterization of ttk1, a P-element insertion within the ttk
locus corresponding to an insertion within the 3’ UTR of the ttk69 isoform and in an
intron in ttk88, demonstrated that tramtrack has an essential role in the developing
Drosophila eye (Xiong and Montell 1993). Ttk88 plays an important role to repress
specific cell-fate determination genes during R7 photoreceptor differentiation (Xiong and
Montell 1993).
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Figure 3: TRAMTRACK69 and TRAMTRACK 88 arise from alternative
splicing

Figure 3: The tramtrack gene gives rise to two different proteins, Ttk69 and Ttk88,
as a result of alternative splicing. (A) The tramtrack gene span covers approximately
21.5 Kb and is located on chromosome 3R. (B) tramtrack gives rise to two alternative
mRNA slice variants, ttk88 (top) and ttk69 (bottom). Both isoforms contain identical 286
amino-terminal residues (dashed box) as well as 5’ UTR regulatory sequences (open
box), but differ in carboxy-terminal residues (gray box in ttk88, black box in ttk69) as
well as 3’ regulatory sequences (open bars). The location of the P-element transposon
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insertion associated with the ttk1 mutant allele is implicated by the black arrow. The
insertion occurs within the 3’ UTR of ttk69 mRNA and an intron within ttk88 mRNA.
ttk69 mRNA is approximatley 4.2 kb and cDNA is approximately 3.7 kb. ttk88 mRNA is
5.0 kB and 4.5 kb respectively. (C) cDNA structure of ttk88 and ttk69 demonstrates large
differences in carboxy-terminal motifs and regulatory regions. Dashed regions imply
identical sequences whereas regions unique to ttk88 and ttk69 are displayed as gray
(ttk88) or black (ttk69) boxes.
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2.10 Drosophila melanogaster wing as a model system
Genes essential for basic cellular and developmental processes have been highly
conserved. Approximately 50% of human genes have counterparts in Drosophila,
making it an excellent model system for understanding how individual genes contribute
to development in flies, as well as humans. The wing provides a unique in vivo model
system to identify factors that regulate cell-fate determination and is one of the only
systems in which alterations in cell-fate can be observed at the single cell level. Several
key components of these conserved pathways were first identified through classical
genetic epistasis experimentation. The Drosophila wing is composed of two cell layers
(dorsal and ventral) and consists of two main cell types (vein and intervein). It has 5
longitudinal veins (L1-L5) and 2 traverse veins, the anterior crossvein (ACV) and
posterior crossvein (PCV). Veins are important for structural support during flight as
well as providing a vessel for blood lacunae, nervous system tissue, and trachea to pass.
The longitudinal veins develop before the crossveins, and are essential for crossvein
development initiation and positioning (Sturtevant and Bier 1995).

2.11 Imaginal discs are precursors for all external adult structures in Drosophila
In flies, adult structures begin as large clusters of epithelium-derived undifferentiated
cells, called imaginal discs, during larval development. Each larva has 1 imaginal disc
located at the midline and 9 pairs of discs symmetrically organized on opposite sides of

30
the midline. The discs undergo rapid cellular proliferation, and the initial stages of
patterning begin, largely based on the spatial and temporal localization of transcription
factors. During pupal development cell fate decisions are completed and the discs grow
and evaginate to eventually give rise to the external adult structures (Figures 4 and 5)

Figure 4: Adult structures are derived from third instar larval imaginal discs

Figure 4: A schematic demonstrating the origin of external adult structures. The
morphology and placement of each pair of larval imaginal discs is shown. Each disc has
a unique morphology and location within the animal. (Taken from Alberts, B. Molecular
Biology of the Cell, 4th edition 2002)
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Figure 5: The larval wing imaginal disc gives rise to the adult wing

A

B

Figure 5: The adult wing is derived from larval wing imaginal discs. (A) The wing
imaginal disc gives rise to the notum, hinge, and wing blade. The location of the L2-L5
proveins, the wing margin, as well as the A/P and D/V axes are depicted. Modified from
Blair, S. (2007) Wing vein patterning in Drosophila and the Analysis of Intercellular
Signaling. Annu. Rev. Cell Dev. Biol. 23:293-319.

(B) A wildtype (OregonR) wing.

The wing is composed of two main cell types, vein and intervein. Longitudingal veins
L1-L5, the Anterior Cross Vein (ACV) and Posterior Cross Vein (PCV) are indicated.
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2.12 An overview of the stages of Drosophila wing development
Wing vein development occurs in two main stages: initiation takes place during the third
larval instar while vein differentiation, refinement, and maintenance all occur during
pupal development. The wing develops during as the third larval instar from the wing
disc, a monolayer of approximately 50,000 epithelial cells. The wing disc has six
planes/axes including anterior/posterior (A/P), dorsal/ventral (D/V), and proximal/distal
(P/D). Vein pattern initiation begins with the appropriate positioning of broad regions
called “proveins” and intervein cells along the A/P axis. These regions can be identified
in early larval stages, based on the localized expression of specific transcription factors.
Cell fate determination into either vein or intervein does not occur until pupal
development (reviewed in (De Celis 2003).
Drosophila wing patterning is extremely complex, involving at least five cell
signaling cascades; Delta/Notch (N), Epidermal growth factor receptor (Egfr), Hedgehog
(Hh), Decapentaplegic (Dpp), and Wnt /Wingless (Wnt/Wg) signaling (Blair 2007).
These pathways are highly coordinated to lead to the proper wing shape, size, and vein
pattern and will be discussed below (Table 1).
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Table 1
Conserved signaling pathways in Drosophila Wing Development
Five Conserved Signaling Pathways Coordinate Wing Development1
Conserved Pathway
Function in Wing Development
Hedgehog (Hh)
Pattern initiation during third larval instar
Required for L4 development
Required for intervein development between L3/L4
Intervein cell proliferation
Decapentaplegic (Dpp)

Epidermal Growth Factor
Rececptor (Egfr)

Delta/Notch (Dl/N)

Wnt/Wingless (Wnt/Wg)

1

Activated in response to Hh signaling
Pattern initiation during third larval instar
Intervein cell proliferation
Required for L2/L5 positioning
Required for vein maintenance during pupal
development
Activated in response to heightened Dpp and Dl/N
signaling
Important for vein initiation and maintenance
Required for development of all longitudinal veins
Activated in response to heightened Egfr signaling
Promotes vein differentiation and maintenance
during pupal development
Required for margin development
Initiated during during third larval instar
Required for cell proliferation
Required for margin development

Each conserved signaling pathway is listed in the left column. The role each pathway plays during wing
development is described in the right column.
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2.13

Development of the Drosophila melanogaster wing imaginal disc:

2.13.1 Hedgehog signaling initiates wing development
Imaginal discs are epithelial sheets of cells that proliferate and differentiate to form most
adult structures, including eyes, wings, and legs (Bate and Arias 1991). During larval
development, wing pattern formation begins as territories of cells divide and acquire
particular cell fates. Both proper cell signaling and localized expression of cell
determination genes are necessary for normal wing development. Vein pattern initiates
with the positioning of longitudinal veins along the anterior/posterior axis. This is when
proveins, broad regions that give rise to eventual veins, and interveins are first defined.
The stripes of proveins and interveins are symmetrical with respect to the dorsal/ventral
boundary. Proveins and interveins differentially express specific transcription factors,
such as blistered (bs) (Fristrom, Gotwals et al. 1994; Montagne, Groppe et al. 1996),
plexus (px) (Matakatsu, Tadokoro et al. 1999), and net (Brentrup, Lerch et al. 2000) in
intervein cells and proveins express vein-specific transcription factors, araucan (ara) and
caupolican (caup) (L1,L3,L5), Abrupt (Ab) (L5), and knirps/knirps-related (knr/knrl)
(L2) (Gomez-Skarmeta, Diez del Corral et al. 1996; Lunde, Biehs et al. 1998; de Celis
and Barrio 2000; Lunde, Trimble et al. 2003). The antero/posterior axis originates from
localized expression of the genes engrailed (en) and Hedgehog (Hh) in the posterior
compartment and the transcription factor cubitus interruptus (ci) in the anterior portion.
When Hh is secreted in the posterior compartment, it diffuses across the disc and forms a
gradient, resulting in the expression of vein-intervein specific factors in a dose-dependent
manner (Basler and Struhl 1994; Zecca, Basler et al. 1995; Vervoort, Crozatier et al.
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1999). Hh signaling is involved in the development of L4 and spacing between L3 and
L4, primarily by activation of the transcription factors knot (kn) and collier (col)
(Nestoras, Lee et al. 1997; Mohler, Seecoomar et al. 2000). Loss of function mutations in
the kn gene result in a decrease in overall wing size, a decrease in the space between
L3/L4, and loss of the L4 vein (Mohler, Seecoomar et al. 2000). Knot regulates
transcription of vein-specific genes, vein (vn) in L4 provein cells and three iroquois
complex (iro-c) genes in the L3 provein, as well as the intervein-specific gene blistered
(bs) in L3/L4 intervein cells (Crozatier, Glise et al. 2002). Vn is an Egfr ligand, so its
expression in the L4 provein can promote vein cell differentiation by activating the Egfr
pathway (Schnepp, Grumbling et al. 1996). The Iroquois complex genes are transcription
factors that promote L3 development by likely regulating rhomboid (rho) expression, a
factor required for processing of the main Egfr ligand, Spitz (De Celis 2003).

2.13.2 Dpp signaling in the wing imaginal disc
Hh mediates long-range patterning by activating Decapentaplegic (Dpp). Cells just
anterior to the A/P boundary respond to high Hh levels, resulting in a stripe of dpp
expression. Dpp is a member of the Transforming Growth Factor receptor-β (TGFβ)
superfamily, and is orthologous to mammalian Bone Morphogenetic Proteins (BMP),
BMP-2 and BMP-4 (Padgett, St Johnston et al. 1987; Newfeld, Padgett et al. 1997). Dpp
is secreted from the A/P boundary, where it spreads across the wing disc and forms a
morphogen gradient. The expression of vein-specific transcription factors is a result of
threshold-dependent Dpp activation. Transcription factors required for L2/L5
development respond to low levels of Dpp, whereas those required for L3/L4
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development respond to high Dpp levels (Entchev, Schwabedissen et al. 2000;
Teleman and Cohen 2000). Dpp signaling is primarily mediated by the activation of two
adjacent genes that code for the zinc-finger containing transcription factors spalt (sal) and
spalt-related (salr) (de Celis, Barrio et al. 1996). The Spalt complex, containing Sal and
Salr, contributes to vein patterning by regulating the expression of vein-specific
transcription factors, including the iro-C genes essential for L1/L3/L5 development, the
knirps-complex genes (knirps and knirps-related) essential for L2 development, and
optomoter blind (omb) essential for L5 development (Gomez-Skarmeta, Diez del Corral
et al. 1996; de Celis and Barrio 2000; del Alamo Rodriguez, Terriente Felix et al. 2004).
In the L2 provein, Kni/Knrl promote vein cell differentiation and link Dpp signaling to
Egfr signaling by activating the expression of rhomboid, a factor essential for processing
of the main Egfr ligand, Spitz (Lunde, Biehs et al. 1998).
Dpp can form a heterodimer with a second ligand, Glass Bottom Boat (Gbb).
Unlike Dpp expression that is limited to specific regions of the wing disc, Gbb is
expressed throughout the imaginal disc (Doctor, Jackson et al. 1992; Khalsa, Yoon et al.
1998). Dpp signaling is received by three members of the TGFβ receptor family serinethreonine kinases. These include two members of the Type I family, THICKVEINS
(TKV) and SAXOPHONE (SAX) and one Type II family member, PUNT (PNT)
(Brummel, Twombly et al. 1994) (Nellen, Affolter et al. 1994; Penton, Chen et al. 1994;
Xie, Finelli et al. 1994; Letsou, Arora et al. 1995; Ruberte, Marty et al. 1995). SAX and
TKV have synergistic roles in positioning of the L2/L5 veins (Singer, Penton et al. 1997).
The binding of Dpp to SAX or TKV results in activation of Dpp signaling. SAX and
TKV also function to sequester the Dpp ligand and prevent differentiation of cells located
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in intervein space into vein fate, as determined by clonal analyses. SAX null or TKV
hypomorphic clones in regions along L2 led the formation of ectopic veins anterior to L2.
The similar phenotype was observed in clones around L5, leading to the formation of
ectopic veins posterior to L5. This data suggested that loss of receptor sequestration of
the Dpp ligand resulted in spreading of the Dpp signal to areas outside of the L2/L5
boundaries and into intervein areas (Singer, Penton et al. 1997). Further, hypomorphic
mutation of tkv leads to the development of thickened veins, a phenotype due to loss of
TKV ability to sequester the Dpp signal and prevent spreading of vein-cell differentiation
(Ruberte, Marty et al. 1995; Haerry, Khalsa et al. 1998)

2.13.3 The relationship between tissue patterning and cell proliferation in larval
development
Hh and Dpp signaling not only result in appropriate provein/intervein patterning, but also
regulates rapid cellular proliferation (Milan, Campuzano et al. 1996). In the developing
wing tissue, synchronized cellular division occurs approximately every 8 hours in
intervein cells. Proveins function as boundaries to restrict these clonal cell divisions,
though the mechanism of restriction that is not well defined (Garcia-Bellido, Cortes et al.
1994; Gonzalez-Gaitan, Capdevila et al. 1994). The Helix-Loop-Helix transcription
factor, EXTRAMACROCHETE (EMC), is expressed in response to Notch signaling in
the developing wing tissue, where it has an important role in regulating cellular
proliferation. Ectopic emc expression in intervein cells leads to an overall decrease in
wing size and loss of intevein cells and resulting fused longitudal vein. This data
suggests that emc has an important role in both promoting vein cell differentiation in
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provein cells, and inhibiting cellular proliferation in intervein cells (de Celis, Baonza et
al. 1995; Baonza and Garcia-Bellido 1999).

2.13.4 Notch and Wnt/Wingless signaling are essential for regulation of cellular
proliferation and D/V patterning of the wing imaginal disc
Wnt/Wingless (Wg) signaling is essential for cellular proliferation within the wing disc,
as the homozygous hypomorphic wg1 mutation can lead to complete loss of wing
development (Sharma and Chopra 1976). Wingless is expressed as a stripe perpendicular
to that of Hh and Dpp, coinciding with the D/V boundary, and is essential for patterning
of the wing margin (Campbell, Weaver et al. 1993). Null mutation of wg is lethal.
Clonal analysis demonstrated that loss of wg expression from within the stripe across the
D/V boundary leads to complete loss of tissue development, indicating an essential role
in both cellular proliferation and patterning (Baker 1988). Mutations in a downstream
Wg effector, armadillo (arm), result in decrease cellular proliferation (Peifer, Rauskolb et
al. 1991). The region where dpp expression along the A/P boundary intersects with wg
expression along the D/V boundary is essential for proper proximal/distal patterning and
overall wing development, as demonstrated by clonal analysis. Overexpression of dpp in
a region outside the intersection lead to the development of an entire ectopic wing
(Zecca, Basler et al. 1995).
Two genes are highly expressed around the A/P / D/V boundary, Distalles (Dll)
and aristaless (al) in response to high levels of both Dpp and Wg (Campbell, Weaver et
al. 1993; Struhl and Basler 1993). In clonal analyses, ectopic expression of al mimics
ectopic wg expression. (Campbell, Weaver et al. 1993). Clonal overexpression of Wg or
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Dpp leads to an overall increase in wing size in a cell autonomous fashion due to
enhanced proliferation (Nellen, Burke et al. 1996; Neumann and Cohen 1996). Notch
signaling is important for inducing wg expression (Diaz-Benjumea and Cohen 1995). Hh
expression along the A/P boundary induces the expression of both dpp and wg. D/V
boundary formation is dependent upon the expression of Apterous (Ap) in dorsal cells
(Blair 1993; Diaz-Benjumea and Cohen 1993). Apterous induces the expression of
Serrate (Ser) and fringe (fng) in dorsal cells (Irvine and Wieschaus 1994; Kim, Irvine et
al. 1995). Short range Ser signaling activates the expression of vestigial (vg) and wg at
the D/V boundary (Couso, Knust et al. 1995; Diaz-Benjumea and Cohen 1995; Kim,
Irvine et al. 1995; Rulifson and Blair 1995). Both wg and vg are direct targets of Notch
signaling, linking Wnt/Wg signaling to both Hh and Notch signaling (Kim, Sebring et al.
1996; Neumann and Cohen 1996).

2.13.5 Notch and Egfr contribute to vein refinement during larval wing disc
development
Hh and Dpp signaling contribute to the expression of a unique set of transcription factors
in each provein, initiating vein development. The signaling pathways essential for vein
refinement and maintenance are common to all longitudinal veins, and involved Notch
and Egfr signaling pathways (reviewed in (De Celis 2003). Activated Egfr and Notch
signaling can be visualized by expression of phoshporylated-MapK (p-MapK) and the
expression of Enhancer of Split-mβ (E(spl)mβ) respectively. Provein cells express
Serrate (Ser) and Delta (Dl), two main Notch ligands, in a narrow stripe down the center,
resulting in activation of Notch signaling pathways in cells directly adjacent to the Ser/Dl
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expressing region. Notch activation leads to the activation of the transcription factor
E(slp)mβ, which is an inhibitor of vein cell differentiation (de Celis, de Celis et al. 1996;
de Celis, Bray et al. 1997). Activation of E(spl)mβ links Notch and Egfr signaling, as
two main Egfr signaling components, rhomboid (rho) and Star (S), are direct targets of
E(spl)mβ (Sturtevant, Roark et al. 1993; Wasserman and Freeman 1997; Perrimon and
McMahon 1999).
There are five key components in Egfr signaling during wing development, rho, S,
Spitz (Spi), Keren (Krn), and argos (aos). Rhomboid (Rho) is a serine protease,
expressed only in provein and vein cells and serves an essential role in vein initiation
because it cleaves the membrane-bound growth factor Spitz, causing its release into the
cytosol and subsequent binding to the Egfr and activation of adjacent cells (Urban, Lee et
al. 2001). Star binds Spitz in the endoplasmic reticulum (ER) and transports it to the
membrane, where it becomes a target of Rho (Tsruya, Schlesinger et al. 2002). Keren is
functionally redundant with Spitz, functioning as an Egfr receptor ligand. Keren
processing is less well understood (Reich and Shilo 2002). Activation of the Egfr results
in receptor tyrosine phosphorylation and activation of the canonical Map Kinase (MapK)
signaling cascade (Gabay, Seger et al. 1997). Narrowing of proveins into veins is
dependent on aos. Aos is a secreted molecule found only in vein cells and functions in a
negative feedback loop to bind and sequester Spitz and prevent its binding to Egfr outside
of vein territories (Golembo, Schweitzer et al. 1996). Egfr signaling functions to repress
Drosophila Serum Response Factor (DSRF) (also known as blistered (bs)) signaling in
provein cells (Sturtevant and Bier 1995). A positive feedback loop linking Notch and
Egfr signaling is initiated when Egfr activation promotes Dl expression within the
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provein. Notch and Egfr signaling are therefore mutually dependant, since Notch
activation initiates the expression of rho, which in turn activates the expression of Dl. (de
Celis, Bray et al. 1997).
Dpp and Egfr signaling pathways appear to converge during pupal development.
This has been determined by studying the development of the L2 vein. As mentioned in
section 2.13.2, L2 development is dependent upon the transcription of knirps/knirpsrelated (kni/knrl), which are expressed in a dose-dependent manner in response to Dpp
signaling (Lunde, Biehs et al. 1998; Lunde, Trimble et al. 2003). The gene rhomboid is a
direct target of KNI/KNRL. Therefore, the Dpp ligand induces KNI/KNRLexpression in
the L2 provein, which results in activation of Egfr signaling by KNI/KNRL induced
transcription of rhomboid expression (Lunde, Biehs et al. 1998). (Figure 6)
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Figure 6 Rhomboid is downstream of Dpp and Egfr Signaling

Figure 6: Rhomboid is downstream of Dpp and Egfr signaling. Activated Egfr and
Dpp signaling results in the development of vein cells. Egfr signaling primarily promotes
the development of veins by increasing rhomboid transcription. Dpp signaling primarily
promotes vein development through a positive feedback loop, with activated Dpp
signaling resulting in dpp transcription. However, activated Dpp signaling can also
promote vein cell differentiation by increasing rhomboid expression. (Figure 6)
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Egfr signaling can also be activated by an addition ligand, vein (vn) in a Rho/S
independent mechanism (Schnepp, Grumbling et al. 1996). Vn signaling occurs in a
nonautonomous fashion and is essential for the development of L4 and the ACV, as
homozygous null mutation, vn1, leads to incomplete L3/L4 and ACV development
(Simcox, Grumbling et al. 1996). The highest levels of vn expression are adjacent to the
A/P boundary, since it is a target of Hh signaling (Crozatier, Glise et al. 2002). In
addition, Egfr signaling is also required to block the expression of blistered (bs) during
provein development (Roch, Baonza et al. 1998).

2.14 Pupal wing development
2.14.1 Maintenance of vein-cell fate requires the activities of Notch and Dpp
signaling pathways
Pattern formation is completed by the end of larval development, with provein and
intervein regions clearly defined based upon the expression of vein and intervein-specific
transcription factors. The actual differentiation of cells into either vein or intervein cell
fate does not occur until pupariation. Dpp signaling is essential for the maintenance of
vein fate at this stage. The expression of dpp switches from the narrow stripe across the
A/P boundary in larval stages, to expression in all provein territories in pupal
development (de Celis 1997). This transition in dpp expression is likely due to a switch
in dpp regulation; dpp is regulated by the 3’ disc regulatory region during larval
development, and the 5’ shortvein regulatory region during pupal development, though
the factors contributing to this switch are largely unknown (Segal and Gelbart 1985;
Blackman, Sanicola et al. 1991). Loss of Dpp signaling during pupal development, as
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observed in dpp

shortvein

shv

(dpp ) mutants, results in loss of the distal-most region of the

longitudinal veins (Segal and Gelbart 1985; de Celis 1997; Sotillos and de Celis 2006).
Proveins narrow during pupal development, primarily as a result of both Notch and Dpp
signaling and the expression of E(spl)mβ and tkv, respectively. Mutations that increase N
signaling cause loss of vein development, whereas those decreasing N signaling cause
vein thickening/broadening (de Celis, de Celis et al. 1996; de Celis, Bray et al. 1997;
Crozatier, Glise et al. 2003). Heightened dpp expression within proveins leads to
repression of tkv expression in the center of each vein, and enhanced expression along
the borders. TKV sequesters the Dpp ligand and prevents the inductive Dpp signal from
spreading into intervein territories, thus hypomorphic tkv, tkv1, mutation results in
thickened veins (de Celis 1997; Haerry, Khalsa et al. 1998).

2.14.2 Anterior and Posterior Crossvein Development occurs during pupal
development
Dpp signaling has an essential role in the development of both Anterior (ACV) and
Posterior (PCV) crossveins. Crossvein development begins much later than longitudinal
vein development at approximately 18-22 hours after puparium formation, and is highly
dependent on Dpp, but not Egfr signaling (Ralston and Blair 2005). Genetic
manipulation of Dpp signaling components can lead to loss of cross vein development,
but have little or no effect on longitudinal vein development. This implies that Dpp
signaling has a more robust role in crossvein initiation than longitudinal vein
development (Yu, Sturtevant et al. 1996; de Celis 1997; Haerry, Khalsa et al. 1998;
Khalsa, Yoon et al. 1998; Nguyen, Park et al. 1998; Ray and Wharton 2001). After
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crossvein development is induced by the expression of Dpp, Egfr signaling becomes
heightened (Conley, Silburn et al. 2000). Like the positive feedback loop observed in
longitudinal vein development, activation of Egfr signaling in the crossveins induces the
expression of dpp. Crossvein development is highly dependent on long-range Dpp
signaling that originates outside of the crossvein region and is derived from the
longitudingal veins (Ralston and Blair 2005). Dpp/Gbb heterodimers are essential for
crossvein development (Conley, Silburn et al. 2000). Several proteins not involved in
longitudinal vein development have an essential role in the developing crossveins,
including crossveinless (cv), crossveinless-2 (cv-2), twisted gastrulation (tsg), Tolloid
(Tld) and short gastrulation (sog). It has been proposed that a complex can form between
Cv, Sog, and Dpp/Gbb heterodimers and that this association allows the Dpp signal to
diffuse across a longer distance than unbound Dpp, and explains how the Dpp signal can
travel into the developing cross vein area from the longitudinal veins (Conley, Silburn et
al. 2000; Ray and Wharton 2001; Ray and Wharton 2001; Ralston and Blair 2005;
Vilmos, Sousa-Neves et al. 2005).
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2.15 Dpp signaling requires binding to THICKVEINS or SAXOPHONE,
members of the TGFβ family
TGFβ-receptor signaling requires heterodimerization of the Type I and Type II receptors.
Type II receptors are responsible for ligand binding and are autocatalytic. Once bound
by TGFβ, Type I receptors can bind the TGFβ-Type II receptor complex, resulting in
phosphorylation of the receptor and activated TGFβ signaling. The phosphorylated Type
I receptor then phosphorylates the downstream effector, receptor SMad (r-Smad).
Phosphorylated r-SMad associates with cofactor- Smads, co-Smads, and the complex is
translocated into the nucleus, where it associates with other factors and leads to specific
gene transcription (Heldin, Miyazono et al. 1997; Massague 1998). In flies, other factors
that either activate or repress downstream Dpp signaling have been identified. Dpp
binding to PUT leads to recruitment and activation of TKV by phosphorylation of the
conserved Ser/Thr residues. TKV phosphorylation leads to phosphorylation of Mad
(pMad) and consequent binding on pMad with Medea. The pMad/Medea complex is
translocated into the nucleus where it regulates downstream Dpp target genes in two
ways. 1) The pMad/Medea complex can directly bind to Dpp signaling target genes and
promote gene transcription. 2) The pMad/Medea complex associates with the
transcription factor, Schnurri (Shn). Shn targets the pMad/Medea/Shn complex to
regulatory regions of brinker (brk) (Marty, Muller et al. 2000). Brinker is a repressor of
Dpp signaling (Minami, Kinoshita et al. 1999). When no Dpp signal is present, Brk
binds to downstream Dpp target genes and represses transcription. Therefore binding on
the pMad/Medea/Shn and subsequent blocking of brk transcription promotes Dpp
signaling (Campbell and Tomlinson 1999; Jazwinska, Kirov et al. 1999; Winter and
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Campbell 2004). Repression of brk is responsible for the role of Dpp in both tissue
patterning as well as cell proliferation (Martin, Perez-Garijo et al. 2004; Schwank,
Restrepo et al. 2008).
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Figure 7: TGFβ signaling in mammals and flies

Figure 7: TGFβ signaling is conserved in humans and flies. (Left) A simplified
schematic demonstrating TGFβ signaling in mammals. (Right) Detailed schematic
demonstrating two mechanisms of gene transcription as a result of Dpp signaling, the
TGFβ ortholog in Drosophila. The pMad/Medea complex contributes to gene activation
by either directly inducing transcription of target genes, or by binding with the
transcription factor Schnurri (Sch). (inset) Brk negatively regulates Dpp signaling by
directly binding to and repressing Dpp target genes Association with Sch recruits the
Sch/pMad/Medea complex to regulatory regions of brk, leading to repression of brk
transcription. Brinker is a negative regulator of Dpp signaling, so repression of brk
transcription promotes Dpp signaling. This figure was adapted from (Gascoigne 2001)
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Dpp activation can be measured experimentally by detecting the levels of
phosphorylated MAD. TKV and SAX heterodimerization with Pnt for activation
(Letsou, Arora et al. 1995). Dpp homodimer or Dpp/Gbb heterodimers are recognized
and bound by Type II receptors, leading to recruitment of the Type I receptor and
subsequent activation of the Dpp signaling cascade (Khalsa, Yoon et al. 1998). At least
in the context of wing development, Dpp/Dpp appears to primarily signal via the
TKV/PUT heterodimer, whereas Dpp/Gbb via the SAX/PUT heterodimer. It has been
proposed that activation of the SAX/PUT heterodimer leads to enhancement of the
PUT/TKV signal and that PUT/TKV/Dpp signaling has a more significant role in wing
patterning than SAX/PUT/Dpp/Gbb (Haerry, Khalsa et al. 1998). This conclusion was
drawn from a couple of key experiments. First, overexpression of dominant negative
forms of TKV or SAX throughout with wing imaginal disc leads to very different
phenotypes. TKV mutation is more drastic, affecting the central region of the wing,
whereas SAX mutation leads to ectopic vein formation around the periphery. Dominantnegative mutation of Pnt leads to the exact same phenotypes as observed with dominantnegative TKV whereas dominant negative mutation of Gbb causes phenotypes similar to
that of dominant negative SAX. If TKV and SAX were serving redundant roles, then
dominant negative mutations in each should lead to similar phenotypes. Furthermore,
Gbb overexpression phenotypes are almost completely suppressed by expression of
dominant negative SAX, but only partially suppressed by dominant negative TKV.
Likewise, ectopic vein phenotypes associated with overexpression of Dpp can be
suppressed by dominant negative TKV, but not dominant negative SAX (Haerry, Khalsa
et al. 1998).
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2.16 The Drosophila wing as a model for identifying factors important for Brm
complex-mediated gene activation/repression activities .
The Drosophila wing serves as an excellent model to understand how each individual
Brm complex subunit contributes to chromatin remodeling activities. Because the
signaling pathways required for proper wing development have been well characterized,
genetic epistasis analyses can help define how independent subunits contribute to
differential regulation of these pathways. For example, BRM promotes vein cell
development, as dominant-negative mutations (brmK804R) leading to loss of ATPase
activities cause shortening of the wing veins (Elfring, Daniel et al. 1998). Mutant
BRMK804R protein is, however, efficiently incorporated into Brm complexes (Elfring,
Daniel et al. 1998). This phenotype is not only reminiscent of loss of function mutations
in Dpp and Egfr signaling components (De Celis 2003), but genetic interaction
experiments suggest that BRM promotes Dpp and Egfr signaling. For example, rhove-1, a
loss of function mutation in a factor essential for processing of the primary EGFR ligand,
leads to shortened wing veins, a phenotype that is enhanced by brmK804R (Marenda, Zraly
et al. 2004).
Factors that contribute to negative regulation of remodeling activity have also
been identified by using the wing model. SNR1 has an important role in
blocking/shielding remodeling activities. This became evident when a dominant-negative
mutation in snr1, snr1E1, caused the formation of ectopic vein material. Further, the loss
of vein phenotype associated with brmK804R, was suppressed by snr1E1, suggesting that
the two subunits have opposite roles in wing development. Genetic epistasis experiments
between rhove-1 and snr1E1 demonstrated an opposite interaction than that observed with
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K804R

brm

, and suggested that SNR1 may negatively regulate Egfr and/or signaling in

intervein tissue.
Several lines of evidence suggest that the Brm complex is involved in both gene
activation and gene repression. Mechanisms for Brm-mediated gene activation have
been more thoroughly described; less well understood are the factors that contribute to
gene repression. One important finding was that Wingless signaling is repressed by the
OSA subunit (Collins and Treisman 2000). Wnt/Wg signaling is one of five pathways
critical for cell fate determination during wing disc development. Loss of Wingless
signaling is associated with loss of wing margin development, and is reminiscent of
phenotypes observed with osa gain of function mutations, whereas ectopic Wg expression
causes phenotypes similar to osa loss of function mutations, demonstrating that OSA may
have an important role in negatively regulating Wg signaling (Collins, Furukawa et al.
1999; Collins and Treisman 2000). Furthermore, negative transcriptional regulation by
OSA is dependent on Brm complex remodeling activity, since ectopic expression of a
dominant negative form of brm (brmK804R) can rescue phenotypes associated with the
overexpression of osa (Collins and Treisman 2000). These studies provided evidence
that each subunit within the Brm complex may have a unique role in contributing to
either promote or repress gene transcription. However, it is interesting that the role of the
OSA subunit in regulating gene transcription appears to be tissue specific, since opposite
effects were observed when osa mutants were expressed in the eye vs. wing (Collins,
Furukawa et al. 1999).
Several examples of Brm complex associations with transcriptional regulators
exist. The trithorax group protein, ZESTE, is a transcriptional activator that can
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physically associate with two subunits, MOR and OSA and mutation of Zeste binding
sites in vivo caused loss of Brm recruitment (Dejardin and Cavalli 2004). Understanding
how BAP and PBAP complexes make unique contributions to gene regulation during
development is an important question and a key finding was made using the wing as a
model. Authors performed a modular P-element based EP (enhancer/promoter)
misexpression screen and looked for factors that when misexpressed led to enhancement
or suppression of a wing phenotype caused by dominant gain of function of dLMO, a
known negative regulator of Apterous expression (Milan, Pham et al. 2004). Apterous is
a transcription factor spacially/temporally expressed during second/third in star wing disc
development and is essential for proper dorsal/ventral patterning (Cohen, McGuffin et al.
1992). Dominant gain of function mutations in dLMO lead to a scalloped wing
phenotype that can be completely suppressed by simultaneous overexpression of osa, and
enhanced when combined with a transheterozygous small deficiencies covering either osa
or brm. These studies show that OSA can both positively regulate (ex. Serrate) and
negatively regulate (ex. delta and fringe) Apterous target genes leading to overall positive
regulation of Apterous expression. This work provided further evidence that physical
associations made between OSA and other coregulators (ex. Chip) are essential for the
specific recruitment of BAP complexes to target genes and suggest OSA may function as
an important targeting component (Milan, Pham et al. 2004).
Dominant genetic modifier screens to identify SNR1-interacting coregulators.
It is highly likely that regulation of BRM complex activities is dependent not only upon
physical associations between complex subunits, but also association of the complex with
coregulatory proteins. A dominant negative mutation (snr1E1) in a core Brm subunit,
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SNF5-Related-1 (SNR1), leads to differential misregulation of genes required for vein
and inter-vein cell development, suggesting possible regulatory targets for the Brm
complex in vivo that included components of the EGFR (Epidermal Growth Factor
Receptor), DPP/BMP (Decapapentaplegic/ Bone Morphogenetic Protein) and NotchDelta signaling pathways. Tissue-specific differential requirements for Brm complex
functions in patterning have been observed (Marenda, Zraly et al. 2004). These studies
revealed that the ectopic veins associated with snr1E1 are dependent on BRM ATPase
chromatin remodeling activity. While BRM ATPase activity is required for proper wing
vein development, SNR1 functions to regulate that activity on specific gene targets (e.g.,
rhomboid) in intervein cells through collaborations with transcriptional repressors (e.g.,
NET) and HDAC activity. An important finding was made when it was discovered that
the observed repression of transcription was due in part to shielding chromatin
remodeling activities, hence the SNR1 subunit has a regulatory role to restrict remodeling
activities in a cell-type, tissue-specific manner (Marenda, Zraly et al. 2004)
The snr1E1 mutant used in these genetic tests is a temperature-sensitive allele that
behaves genetically as both a loss-of-function hypomorph and a weak dominant-negative.
The mutation affects a nearly invariant glycine (G256) residue within the second repeat
region, a highly conserved irregular repeat region known to be involved in multiple
protein-protein interactions (Marenda, Zraly et al. 2003). Heterozygous snr1E1 flies
exhibit ectopic wing vein material perpendicular to the posterior cross vein (PCV) and
anterior to longitudinal vein L2. The defects are apparent at the permissive (18˚)
temperature, with increased penetrance at the restrictive (29˚) temperature. The
phenotypes are sensitive to snr1 gene dosage and are enhanced or suppressed by
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mutations in other Brm complex genes, revealing that SNR1 directly regulates aspects
of Brm complex activity (Marenda, Zraly et al. 2003). The mutant phenotypes result
from reduced or compromised SNR1 function, rather than complete disruption of Brm
complex activities (Marenda, Zraly et al. 2003; Marenda, Zraly et al. 2004) as snr1E1
produces a stable protein that is assembled into Brm complexes at both temperatures
(Marenda, Zraly et al. 2003). Thus, SNR1E1 complexes form and bind their targets but are
defective in some other functions. A large chromosomal deletion that completely
removes the mor gene acted as a suppressor of the dominant negative snr1E1 wing
phenotype, while a hypomorphic mor allele acted as an enhancer, suggesting that SNR1
and MOR were capable of direct collaboration within the Brm complex.
In order to identify factors that modify SNR1 repression functions in vivo and to
identify possible coregulators of Brm complex activity, an unbiased dominant modifier
genetic screen using an ordered set of chromosomal deficiencies that removed ~85% of
the euchromatic genome was performed. Each deficiency was independently tested for a
genetic interaction with snr1E1. Deficiencies that enhanced/suppressed the wing
patterning phenotype associated with the temperature-sensitive snr1E1 mutation were
further analyzed to identify novel coregulators of the Brm complex in controlling gene
expression. I determined if deficiencies removing a common functional group of
transcriptional regulators genetically interacted with snr1E1. I identified histone lysine
demethylase enzymes (KDMs) as potential mediators of Brm chromatin remodeling
activities (Curtis et. al 2010, in preparation). The scope of my project focuses on
understanding how one particular demethylase enzyme, dLSD1, contributes to Brm
chromatin remodeling activities. In this work, I will demonstrate a functional
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relationship between dLSD1 and the BRM complex, and propose that dLSD1 has an
important role in regulating cell-fate choices during wing development.

CHAPTER 3
MATERIALS AND METHODS
3.1 Fly stocks and genetic analyses:
All Drosophila stocks were maintained on standard yeast/cornmeal/dextrose medium at
25°C, except for snr1E1,e/TM6B,Hu,e which was maintained at 29°C. All moira (mor)
alleles were kindly provided by James Kennison. lsd1∆N/TM6B was kindly provided by
Nicolas Dyson. All other strains were obtained from the Indiana University-Bloomington
Drosophila stock center and RNAi lines from the Vienna Drosophila Resource Center
(Vienna, Austria). All strains and gene mutants are described in detail in Flybase (http://
flybase.bio.indiana.edu).

3.2 Genetic Epistasis experiments: Females of the genotype snr1E1,e/TM6B,Hu,e were
crossed to males harboring the mutation of interest, unless otherwise indicated. Crosses
were carried out at 29°C and progeny scored for enhancement or suppression of the
snr1E1 posterior cross vein wing phenotype (Marenda, Zraly et al. 2003; Marenda, Zraly
et al. 2004). Genetic analyses involving other Brahma complex components were carried
out at 25°C.
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3.3 P-element mobilizations: Virgin female y1w67c23; P(w+,lacW)lid2/Cyo flies were
crossed to male w-; wgsp1/Cyo; ∆2,3 Sb/TM6B. Virgin w-; lid2/CyO; ∆2,3 Sb/+ were
crossed to male w-; Sco/Cyo. Virgins carrying potential excisions (w-; lid2REV/Cyo; +/+)
were selected based on the loss of miniwhite gene and individually crossed to male w-;
Sco/CyO flies. w-; lid2REV/CyO siblings were crossed to build stocks. w-; lid2REV/Cyo flies
were crossed to Df(2L)Ed354/SM6a, a deficiency covering lid. The lid2 insertion is
lethal, so the presence of lid2REV/Df(2L)Ed354 progeny indicated that the P-element had
been precisely excised. Virgin y1w67c23; P{w[+mC]y[+mDint2]=Epgy2]}CG3654EY02717
flies were crossed to w-; wgsp1/Cyo; ∆2,3 Sb/TM6B. Male y1w67c23/Y; Cyo/+;
P{w[+mC]y[+mDint2]=Epgy2]}CG3654EY02717/ ∆2,3 Sb were crossed to virgin wTM3/TM6B flies. Virgin female potential excision recombinants were collected based on
loss of red eye color, w-[+mC]y[+mDint2]=Epgy2]}CG3654EY02717REV / TM6B, and were
individually crossed to male w-; TM3/TM6B flies. w [+mC]y[+mDint2]=Epgy2]}
CG3654EY02717REV / TM6B siblings were crossed to generate stocks. The Epgy P-element
is always precisely excised. Therefore, I assumed that loss of the miniwhite gene
corresponded to precise excision of the P-element from within the CG3654 gene.

3.4 Yeast two-hybrid protein interaction studies:
Protein interaction trap assays were performed in yeast strains using the pRF4-5o and
pEG202 vectors (a kind gift from R. Finley). Four SNR1-B42AD fusions, SNR115-370,
SNR115-240, SNR1240-370, and SNR115-370 G256D have been previously described
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(Zraly, Marenda et al. 2004). The MOR, LSD1, and ADA2 fusions were initially
constructed in the pEG202 vector and tested for protein-protein interaction with the
SNR1 fusions. Full-length mor, lsd1, and ada2a cDNAs were obtained from the DGRC
(http://dgrc.cgb.indiana.edu/) and regions of interest were amplified using standard PCR
procedures (ExTaq; Takara, Inc.). Xho1/BamH1 mor fragments and EcoR1/Xho1 lsd1
and ada2a PCR fragments were independently cloned into pSK+, screened, and
subcloned into the bait LexA pEG202 yeast vector. All constructs were transformed into
yeast of opposite mating type (RFY231 and Y309), mated to produce diploids, and
assayed for protein-protein interaction based on the production of

-galactosidase (lacZ)

and growth on plates lacking leucine, as described previously (Finley, Thomas et al.
1996). Each pair mating was tested in triplicate. For LSD1–MOR interaction analyses,
the LSD1 and MOR SANT constructs were built into the pRF4-5o vector using the same
technique described above. The QuikChangeII Site-Directed Mutagenesis Kit
(Stratagene) was utilized to create the specific (I350P) point mutations in snr1 sequences
according to manufacturer protocols. Mutations were confirmed by sequencing.

3.5 Immunohistochemistry:
Appropriately staged (Bainbridge and Bownes 1981) pupal wings were dissected, fixed,
and immunostained with anti-LSD1 (1:1000) antibody (a kind gift from Nicolas Dyson).
Pupae were removed from pupal cases and fixed in 4% formaldehyde for 30 minutes.
Pupal wings were then dissected in PBST and removed from cuticular envelopes. Pupal
wings were washed 3X in PBST and then incubated in normal goat serum (blocking) for
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1 hour at 4ºC. Blocking solution was removed and wings were incubated with either
rabbit anti-LSD1 (1:1000) or PBS (negative control) at 4ºC overnight. Samples were
washed 4X in PBST and then incubated with goat anti-rabbit-HRP (1:500) (Sigma) for 12 hrs at room temperature. Samples were again washed 3X in PBST and then developed
as described previously (Marenda, Zraly et al. 2003).

3.6 LacZ stainings: The regulation of rhomboid transcription during pupal wing
development was tested by using the rholacZX81 reporter gene, as previously described
(Marenda, Zraly et al. 2004). Pupae were removed from the pupal case and fixed in 1.5%
glutaraldehyde for 15-20 minutes. The samples were washed and pupal wings were then
dissected and freed from the cuticular case. Pupal wings were stained in a prewarmed
solution of solution [10mM NaH2PO4.H2O/ Na2HPO4.2H2O (pH 7.2.), 150 mM NaCl,
1mM MgCl2, 3.1 mM K4[FeIII(CN)6], 3.1 mM K3[FeII(CN)6], 0.3% Triton X-100] with
X-gal (25

l of 8% X-gal in DMSO). Samples were incubated at 37°C for 12-24 hours.

The reaction was stopped by the addition of PBS. Pupal wings were mounted in glycerol
and examined using an Olympus BX41 microscope.

3.7 Single fly PCR Single male flies were squished in a buffer containing 1M Tris, pH
8.2, 0.5M EDTA, pH 8.0; 5M NaCl and 20 mg/ml proteinase K. The sample was
warmed to 95°C for 30 minutes followed by a 5 minute incubation at 4°C. Samples were
centrifuged to remove debris and the supernatant containing the DNA was collected and
stored at 20°C for later use in standard PCR reactions.
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3.8 Generation of recombinant stocks
3.8.1 lsd1∆N, rhove-1/ rhove-1 recombinant stock
Female lsd1∆N /TM6B were crossed to male w- rhove-1. w-; lsd1∆N/rhove-1 females
were crossed to w-;TM3/TM6B males. Potential lsd1∆N, rhove-1 /TM3 or TM6B
recombinants were selected based on the orange eye color associated with the
miniwhite gene transposon insertion in lsd1∆N and crossed to w-; rhove-1 virgins.
Potential lsd1∆N, rhove-1 recombinants displaying the shortvein phenotype
associated with homozygous rhove-1were then crossed to lsd1∆N. If all progeny
were balanced, an lsd1∆N, rhove-1/TM6B stock was generated.

3.8.2 GawB69B, rholacZ recombinant stock
GawB69B females were crossed to rholacZ/TM3 males. Virgin
GawB69B/rholacZ females were crossed to w-; TM3/TM6B males. Potential
GawB69B,rholacZ/TM3 or TM6B recombinants were crossed to w-; TM3/TM6B
and stocks were generated. Stocks were tested for the presence of GawB69B and
rholacZ by performing single fly PCR using primers against GAL4 and LacZ
respectively.

3.8.3 bsGAL4; TM3/TM6B stock
bsGAL4 males were crossed to w-; TM3/TM6B virgin females. bsGAL4/+;
TM3/+ virgin females were crossed to bsGAL4/+; TM6B/+ males.
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bsGAL4/bsGAL4 or + ; TM3/TM6B animals were self crossed. If all progeny had
red eyes (from the w+ transgene carried on the bsGAL4 transgene), then siblings
were crossed and progeny observed for eye coloration. Stocks were verified
using single fly PCR and primers against GAL4.

3.8.4 w-Sco/CyO; rholacZ/TM3 stock
w-; Sco/CyO virgin females were crossed to rholacZ/TM3 males. w-; Sco/+;
rholacZ/+ flies were crossed to w-; CyO/+; TM3/+ flies. w-; Sco/CyO;
rholacZ/TM3 flies were self crossed to build a stock.

3.8.5 bsGAL4; rholacZ stock
bsGAL4; TM3/TM6B virgin females were crossed to w-; Sco/CyO; rholacZ/TM3
males. w-; bsGAL4/CyO; rholacZ/TM3 siblings were crossed. bsGAL4; rholacZ
progeny were crossed to create a stock.

3.8.6 ttk1; rhove-1 stock
ttk1/TM3 virgin females were crossed to rhove-1 males. ttk1/rhove-1 virgin females
were crossed to w-; TM3/TM6B males. Potential ttk1, rhove-1/TM3 or TM6B
recombinants were crossed to w-; TM3/TM6B. Potential ttk1, rhove-1 recombinants
were crossed to rhove-1 homozygotes. If progeny displayed the short-vein
phenotype associated with homozygous rhove-1, potential ttk1, rhove-1 recombinants
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were crossed to ttk1/TM3. ttk1 is homozygous lethal, so if all progeny were
balanced, ttk1, rhove-1/TM3 stocks were built.

3.8.7 dCoRESTEY14216; TM3/TM6B stock
dCoRESTEY14216 virgin females were crossed to w-; TM3/TM6B males.
dCoRESTEY14216/w-; TM3/+ virgin females were crossed to dCoRESTEY14216/Y;
TM6B/+ males. Dark orange eyed (indicates multiple copies of the miniwhite
insertion carried on the transposon inserted in the dCoREST gene)
dCoRESTEY14216; TM3/TM6B virgin females were crossed to dCoRESTEY14216/Y;
TM3/TM6B males to generate stocks. The stocks were verified to have all orangeeyed flies after several generations.

3.9 Mounting wings: Wings were dissected from female flies, unless otherwise
indicated. Adult flies were dissected in isopropanol and whole wings were mounted in
DPX (Fluka #44581). Wings were photographed at 63X magnification using a Leica
MZ16 stereo dissecting microscope.
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Table 2
Primer Sequences
Primer Name
LSD1-IR VDRC (Left )
CoREST-IR VDRC (Left)
MorSwirmR1 trunc
Exon3LSD1
R1 LSD1 downstream ofP
LSD1-Not1 (F1)
SNR1CCptmut (R1)
SNR1CCptmut (F1)
MorSwmD374A F1
MorSwmD374A R1
MorSwmE323A F1
MorSwmE323A R1
gLSD1 upstream P
gMOR SWRIM F1
gMOR SWIRM R1
BamH1 F1 LD06146
Sal1 R1 LD06146
pOT2 3’ EST SEQ
PiggyBac 5R2
Sal1 dLSD1 F1
XSal1 dLSD1-R1
3’f00678B
F1 Ada2a Swirm
R1 Ada2a Swirm
MOR SANT F1
MOR SANT R1
pEG202 Seq F1
pEG202 Seq R1
Gal4 F1 primer
Gal4 R1 primer
Demethylaseswirm F1
Demethylaseswirm R1
MorSwirm F1
Morswirm R1
F1 LSD1 Nterm
R1 LSD1 Nterm
F1 LSD1 Cterm
R1 LSD1 Cterm

Primer Sequence (5’-3’)
CGCGAATTCGAGCCCACGCCCAAAAGAAAC
CGCGAATTCAAACGGAACGGCAAGAGCAAGG
ATACCGCTCGAGGCCCCATTGCTCCAAGAAG
CCAGCAGTTACTCCTAGAGCGTTTAGTTTT
GTAGCCGATAAAGAGCAACGAACTTAGA
ATAAGAATGCGGCCGATGAAACCCACCCAGTTC
GCGGTCCTGGTCGCGGGGTTTCTTCTCCATTTC
GAAATGGAGAAGAAACCCCGCGACCAGGACCGC
GTAATCTTGCCGGAGCTGTGTGCGCCATAATGC
GCATTATGGCGCACACAGCTCCGGCAAGATTAC
CCATTCATGTGATCGCGAAACGGGCCATGC
GCATGGCCCGTTTCGCGATCACATGAATGG
CGAGACCCAAAACATTACCG
AGCAGACGCACCACATTATC
GGACATCCGCATCGATCT
CGGGATCCCGGGACAATCGACGGGTAGAGA
GTCGACGTCGTTTTCGGCTTTGAAACTTGG
CGTTAGAACGCGGCTACAAT
TCCAAGCGGCGACTGAGATG
ACGCGRCGACTCATGAAACCCACCCAGTTCG
GTTTCCGCTGGTTGATCATT
CTAGGTCGGTTCTGCTCCAG
CCGGAATTCGATGGCGAGCGAAAGTTGT
CCGCTCGAGGACGGTGGTCTGCTGATATG
GGAATTCCCAAGCATGGCTCGTGAATG
CCGCTCGAGCGGCCTCTAGATACGGGTCCTCGA
CAGAGCTTCACCATTGAAGGGC
ACCTGACCTACAGGAAAG
CCGAATTTGGTGGTCTGTCT
AATTGGTTAGAGCGGTGGTG
CGGATCCGGGTTTTGTCTGGCCAAGAGG
CCGCTCGAGCGGGTCGCTTAAAGATGCCGAAG
CGCGGCTCCGCGACAATGTGACCGAGCAGAC
CCGCTCGAGCGGATCCGCATCGATCTGGTAGT
CCGGAATTCCGGATGAAACCCACCCAGTTCG
CCGCTCGAGGTCGCTTAAAGATGCCGAAG
GGAATTCCCTATACCCGCCAAAAAGCTG
CCGCTCGAGCCTCCGACTTCTTTGACGAC

Chapter 4
Results
My dissertation project focuses on understanding how the Brm complex regulates
target genes over the course of development. I was specifically interested in identifying
cofactors that cooperate with the complex to repress target gene transcription. I focused
on SNR1, a regulatory Brm complex subunit. There are two possible mechanisms of
SNR1 mediated complex regulation: (i) physical associations between individual subunits
within the complex and (ii) physical association between the Brm complex and other
coregulatory proteins. My dissertation explores and examines both of these possibilities.

4.1 The Brm complex subunits SNR1 and MOR directly collaborate to regulate
target genes. Several lines of evidence suggest an important functional relationship
between two highly conserved BRM complex components, SNR1 and MOIRA (MOR).
First, the mammalian SNR1 (SNF5/INI1/BAF47/SMARCB1) and MOR orthologs
(BAF155/SRG3/SMARCC1 and BAF170/SMARCC2) are required for full BRG1
remodeling activity in vitro (Phelan, Sif et al. 1999). Second, a physical interaction has
been observed between murine SNR1 and MOR orthologs (SNF5 and SRG3) via the
SRG3 SWIRM domain that is important for protein-protein interactions (Sohn, Lee et al.
2007). RNAi-mediated knockdown of the core subunits, brm, snr1, and mor in cultured
Drosophila S2 cells revealed nearly identical expression profiles in whole genome array
64

65
(Moshkin, Mohrmann et al. 2007), suggesting the holoenyme is required for general
transcription. Finally, genetic epistasis tests in Drosophila using mutant alleles of snr1
and mor confirmed a strong in vivo interaction (Marenda, Zraly et al. 2003).

4.2. SNR1 and MOR have an important in vivo relationship To examine the SNR1MOR functional relationship in more detail, I performed additional genetic interaction
tests between snr1E1 and several independent mor alleles, as well as a deficiency
(deletion) (Df(3R)Exel7327) that removed mor and 18 surrounding genes. I observed
strong allele-specific enhancement of the snr1E1 wing phenotype with several
hypomorphic mor alleles and a C-terminal deletion (mor6) that removes the predicted
leucine zipper, a motif important for homo-oligomerization (Table 3). Unlike the larger
deletion previously demonstrated to suppress the snr1E1 phenotype (Marenda, Zraly et al.
2004) I observed strong enhancement when animals were doubly heterozygous for snr1E1
and Df(3R)Exel7327 as well as a strong loss of function allele (mor3) (Fig. 8). Other mor
mutant alleles, including a predicted null (mor2), exhibited suppression of the wing
phenotype (Table 3). Several explanations exist to expain the opposite genetic
interactions between snr1E1, the null allele, mor2, and the larger deficiency. The most
likely explanation is that the deficiency deletes a second gene, other than mor, that may
cooperate with the Brm complex to regulate target genes, or may have an independent
role in tissue patterning. These data confirm an important functional relationship
between SNR1 and MOR in regulating Brm complex target genes.
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Figure 8: snr1E1 genetically interacts with a loss of function mor allele

Figure 8: Animals transheterozygous for snr1E1 and loss of function mor alleles
display a strong genetic interaction. (A) An OregonR (wildtype) wing has 5
longitudinal veins (L1-L5) and 2 crossveins, Anterior Crossvein (ACV) and Posterior
Crossvein (PCV). (B) snr1E1/+ heterozygous flies have ectopic vein material distal to the
PCV (arrow). (C) snr1E1/Df(3R)Exel7327 transheterozygous flies have an enhanced
ectopic wing vein phenotype, with ectopic material distal to the PCV, as well as anterior
and posterior to L2 (arrows). (D) mor3/+ enhances the snr1E1/+ ectopic vein phenotype.
snr1E1/mor3 transheterozygous flies display ectopic vein material distal to the PCV and
anterior to L2. (arrows). All pictures were taken at the same magnification (63X) and
crosses were set at 29°C.
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TABLE 3
Allele specific genetic interaction between snr1 and mor

Genotype
snr1E1/+
mor1/+
snr1E1/ mor1
mor2/+
snr1E1/ mor2
mor3/+
snr1E1/ mor3
mor4/+
snr1E1/mor4
mor5/+
snr1E1/mor5
mor6/+
snr1E1/mor6
snr1E1/Df(3R)Exel7327
1

Total
Wings
207
152
116
267
168
319
100
106
230
130
102
241
148
118

(-)
67
94
31
100
97
48
23
100
76
66
46
56
41
12

Severity of Phenotype1
(+)
(++)
30
6
39
0
3
38
15
0
23
22
34
40
23
8

3
0
30
0
0
14
62
0
1
12
20
4
36
80

Severity of phenotype was scored as follows: (-) normal vein pattern, (+) single extra vein near posterior
cross vein, (++) two or more wing veins near PCV, anterior to longitudinal vein L2 or posterior to
longitudinal L5. Numbers are expressed as percentages of the total wings examined for each genotype.
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4.3 The C-terminal portion of SNR1 is required for physical association with MOR
The BRM, MOR and SNR1 subunits have been proposed to function as the core
components of all Brm and metazoan SWI/SNF complexes. MOR (BAF155, BAF170)
has been postulated to serve as the bridge between the subunits (Crosby, Miller et al.
1999; Phelan, Sif et al. 1999; Moshkin, Mohrmann et al. 2007) making it likely that the
regulatory functions of SNR1 on BRM ATPase activity are mediated through SNR1
contacts with MOR. Therefore, I sought to identify the region of SNR1 essential for
interacting with MOR by performing a series of yeast 2-hybrid analyses (Figure 9)
The SNR1 protein is composed of three distinct regions, two irregular repeat
regions (Repeat 1 (R1) and Repeat 2 (R2)) both of which are essential for heterotypic
protein-protein interactions, and a predicted coiled-coil (CC) region also possibly
involved in protein interactions (Dingwall, Beek et al. 1995; Morozov, Yung et al. 1998).
The MOR protein contains several predicted protein interaction motifs, including a
leucine zipper region, SWIRM and SANT domains (Crosby, Miller et al. 1999). I
constructed several SNR1 deletion derivatives fused to the B42 activation domain and
tested them for interaction with portions of MOR fused to the LexA DNA binding
domain, including the SWIRM region implicated in mediating interactions between the
murine homologs (Sohn, Lee et al. 2007). A robust interaction was observed between the
C-terminal portion of SNR1 (consisting of R2 and CC regions) and the MOR SWIRM
region; however, I did not detect interactions between SNR1 and the SANT domain.
The COILS program (Lupas, Van Dyke et al. 1991) predicts that amino acids
338-364 of SNR1 have approximately 50% probability of forming a coiled-coil structure.
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Within this region M346, I350, M360, and A364 are predicted to have essential roles
in formation and stability of the coiled-coil structure, as they are located in the seam joining
the two helices. The presence of a proline residue in any of these positions is predicted to
considerably alter the alpha helical structure by forming a kink in the helices and an I350P
conversion would decrease the probability of forming a coiled-coil to less than 1% (Figure
10). Substitution of I350 with a proline residue in the full-length SNR1 did not disrupt the

physical association with the MOR SWIRM domain, suggesting that residues within the
SNR1 CC region, rather than the formation of a coiled-coil structure, were necessary for
the observed protein interaction (Fig. 9).
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Figure 9: MOR SWIRM physically associates with the C-terminal region of SNR1

Figure 9: The C-terminal region of SNR1 physically interacts with the MOR
SWIRM. SNR1-B42 Activation Domain (AD) fusion proteins were tested for physical
interaction with MOR-LexA DNA Binding Domain (DBD) fusions in yeast 2-hybrid.
The SWIRM, SANT, and LEUCINE-ZIPPER (ZIP) domains of MOR, and REPEAT
REGION 1 (R1), REPEAT REGION 2 (R2), and COILED-COIL (CC) domains of SNR1
are indicated. Protein interactions were assessed by the production of beta-galactosidase
(blue colony formation) and, independently, growth on media lacking leucine. Robust
interactions were observed between the MOR SWIRM (aa 442-552) and two SNR1
fusions, SNR1 (aa 15-370) and SNR1 (aa 240-370). Loss of the C-terminal region
(SNR1 aa15-240) resulted in loss of the interaction. The SNR1 I350P mutation
physically associated with the MOR SWIRM. The G256D mutation (as carried in snr1E1
mutants) strongly interacted with the MOR SWIRM. The MOR SANT (aa 648-704)
fusion served as a negative control and had no interaction with SNR1 15-370.
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Figure 10: Coiled-coil conformation prediction for SNR1 and SNR1I350P

Figure 10: SNR1I350P is predicted to reduce the probability of coiled-coil
formation from approximately 50% to 0.5%. Y-axis = Probability of Coiled-coil
formation, X-axis = amino acid residue number. Structural prediction and output charts
were created using the COILS program. Lupas, A., Van Dyke, M., and Stock, J. (1991)
Predicting Coiled Coils from Protein Sequences Science 252:1162-1164.

4.4 The MOR SWIRM domain physically associates with SNR1 My next goal was to
understand which regions of the MOR SWIRM domain were important for the SNR1-MOR
interaction. Supporting evidence for a physical interaction between these core subunits
exists. First, a 2-hybrid library screen studying Drosophila proteins provided evidence

that SNR1 directly associates with the C-terminal portion of the MOR SWIRM domain
(Formstecher, Aresta et al. 2005). In these studies, a full length SNR1 bait fusion
construct was tested for interaction with a library of various overlapping prey constructs,
composed of full or partial protein sequences. The strongest prey fusion construct to
interact with SNR1 was MOR. The Selected Interaction Domain (SID)® was determined
by aligning positively interacting constructs and determining the common area of all
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overlapping fragments. The MOR SID® interaction with SNR1 consists of the Cterminal portion of the MOR SWIRM domain. It has also been demonstrated using
mammalian proteins that the N-terminal portion of the SRG3 SWIRM (the mouse homolog
of MOR) was important for its binding to another complex component, Bap60, and the Cterminal portion of the SWIRM domain, especially the last six amino acids, were essential to
bind SNF5/Ini1 (the mammalian homolog of SNR1) (Sohn, Lee et al. 2007). To further
characterize the SNR1-MOR interaction in Drosophila, I generated a LexA-DBD fusion
construct that contained the C-terminal portion of the SWIRM domain (MORSID aa 482539). This construct carried the fragment of MOR identified as the MOR SID® in the
hybrigenics analyses. I also generated a LexA-DBD fusion construct that contained the full
SWIRM domain (MOR SWIRM aa 442-552), as well as a LexA-DBD fusion construct that
carried the MOR SANT (MORSANT aa 648-704) domain as a negative control. I tested
these LexA-DBD-MOR fusion onstructs for physical interaction with an almost full length
SNR1 (SNR1 aa 15-370)- B42-AD fusion construct in yeast 2-hybrid analyses. A positive
interaction was qualitatively determined by observing the intensity of blue colony formation
and amount of growth on media lacking the leucine amino-acid supplement. I found that the
fusion construct containing the MOR SWIRM domain strongly interacted with SNR1, but
that loss of the N-terminal region (MORSID) weaked the protein-protein interaction (TABLE
4). These results suggest that while the C-terminal region of the MOR SWIRM domain is
sufficient for binding SNR1, the N-terminal region has an important contributes to the
interaction.

73

TABLE 4
N-terminal SWIRM truncation decreases protein-protein
interaction with SNR1
Interaction Pairs
B42 / LexA
SNR1 (aa 15-370) / MOR SWIRM (aa 442-552)
SNR1 (aa 15-370) / MOR SID (aa 482-539)
SNR1 (aa 15-370) / MOR SANT (aa 648-704)
SNR1 (aa 15-370) / pEG202
1

LacZ activity1
++
+
-

A table summarizing results from 3 independent yeast 2-hybrid protein-protein interaction analyses. A
positive protein-protein interaction results in LacZ transcription and blue colony formation on minimalmedia plates containing Xgal. The degree of interaction was qualitatively determined by observing the
intensity of blue color development. (-) no interaction, (+) weak interaction, (++) strong interaction.
SNR1 FULL/pEG202 served as a negative control, and showed no blue colony formation.
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4.5 Protein modeling of the yeast SWI3 SWIRM domain suggests conserved residue,
E323, is important for tertiary structure formation. The SWIRM domain has also been
studied in vivo. In yeast, mutants lacking the SWIRM domain of SWI3, the MOR homolog,
were incapable of complementing the growth phenotype associated with a swi3 null
mutation, demonstrating the SWIRM domain is essential (Da, Lenkart et al. 2006). Mutants
carrying truncations and point mutations resulted in growth defects and a decrease in the
ability of SWI3 to incorporate into the SWI/SNF complex. Specifically, mutation of E323A
within the SWI3 SWIRM domain led to strong growth defects and decreased incorporation
into the SWI/SNF complex (Da, Lenkart et al. 2006). Therefore, I hypothesized that this
point mutation may cause decreased binding with SNF5, the yeast SNR1 homolog, since it
has decreased incorporation into the SWI/SNF complex. This residue is conserved across all
SWIRM domain containing proteins and is essential for stabilizing the multi-helical structure,
as demonstrated by Nuclear Magnetic Resonance (NMR), X-ray crystallographic analysis,
and computer modeling (Yoneyama, Tochio et al. 2007). It has been demonstrated that an
electrostatic interaction forms between a highly acidic glutamate residue in alpha helix I, and
a basic arginine residue in alpha helix III, the long central helix (Yoneyama, Tochio et al.
2007) (Figure 11).
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Figure 11: Protein modeling of the yeast SWI3 SWIRM domain

Figure 11: Protein modeling of the yeast SWI3 SWIRM domain. (A) Ribbon
modeling of the wildtype yeast SWI3 SWIRM domain. The SWI3 SWIRM is composed
of one long central alpha helices surrounded by three smaller α-helices. α-helix I is
depicted in blue, α-helix II in green, α-helix III in yellow, and α-helix IV in red. (B) An
electrostatic interaction connecting E323 of helix I (blue ribbon) to R347 of helix II
(green ribbon) is observed (dashed green lines). The E323 residue is homologous to
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MOR E468. (C) The electrostatic interaction connecting E323 of α-helix I to R347 of
helix II is lost with the E323A substitution. Note the loss of the dashed green line
(indicating an electrostatic interaction) connecting E323 to R347 as observed in (B). (D)
The D374 residue is located in the loop connecting helices III and IV. Mutation of this
residue is not predicted to disrupt the SWIRM structure. This residue is homologous to
MOR D519. (E) Space-filling model of wild-type SWI3 SWIRM demonstrating that a
binding pocket is formed on the loop1/3/5 face. In murine studies, the 4 most C-terminal
amino acids of L5 are essential for the interaction with the SNR1 homolog. Helices 1-4:
blue, yellow, red, green (consecutively); Loop 1: top gray; Loop 3: bottom gray; Loop
5/binding pocket: white (F) Space-filling model of the SWI3 SWIRM showing the
location of the point mutation that will eliminate electrostatic bridge formation. A strong
intra-atomic electrostatic interaction occurs between E323 of helix I and R413 of helix II
and is buried below the binding pocket (orange residues). These residues are predicted to
be essential for SWIRM structure. Helices 1-4: blue, yellow, red, green (consecutively).
Loop 1: top gray; Loop 3: bottom gray; Loop 5/binding pocket: white. Modeling was
carried out using DeepView/Swiss-PdbViewer (http://www.expasy.org/spdbv/) based on
X-ray diffraction structural analysis (Brookhaven protein database 2FQ3) as described in
(Da, Lenkart et al. 2006).
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4.6

Point mutation of conserved residues within the MOR SWIRM domain does not

prevent the physical association with SNR1. To determine if this highly conserved
glutamate residue in the MOR SWIRM domain (E468) is essential for the Drosophila MORSNR1 interaction, I used a site directed mutagenesis approach to create two independent
substitutions. The first mutation is a glutamate to alanine substitution of amino acid residue
number 468 (E468A). This is the residue predicted to be essential for electrostatic bridge
formation in all SWIRM domains. I also created a point mutation that substituted arginine,
amino acid residue number 519 in the MOR SWIRM, with alanine (D519A). This residue is
also conserved, but not predicted to be important to SWIRM structure, as it is located in one
of the loops connecting the alpha helices. In the yeast study described above, mutation of
this particular amino acid residue did not have a growth phenotype or decreased
incorporation into the SWI/SNF complex (Da, Lenkart et al. 2006). Therefore, I predicted
that the MOR SWIRM D519A mutation would not affect the ability of the SWIRM domain
to associate with SNR1. Indeed, I found that both point mutants, E468A and D519A,
physically interact with full length SNR1 in yeast 2-hybrid experiments, suggesting that the
formation of the binding pocket created by loops 1, 3, and 5 is not essential for the SNR1MOR interaction (Table 5)
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TABLE 5
MOR SWIRM point mutant retains binding with SNR1

Interaction Pairs
B42 / LexA

LacZ activity

SNR1 (aa 15-370) / MOR SWIRM (442-552)
++
SNR1 (aa15-370) / MOR (442-452, E468A)
++
SNR1 (aa15-370) / MOR (442-552, D519A)
++
SNR1 aa15-370) / pEG202
1.
A table summarizing results from 3 independent yeast 2-hybrid protein-protein
interaction analyses. A positive protein-protein interaction results in LacZ transcription
and blue colony formation on minimal-media plates containing Xgal. The degree of
interaction was qualitatively determined by observing the intensity of blue color
development. (-) no interaction, (+) weak interaction, (++) strong interaction. SNR1
FULL/pEG202 served as a negative control, and showed no blue colony formation.

4.7 Candidate genetic screen identifies histone demethylase enzymes as potential
Brm complex coregulators Daniel Marenda, a former graduate student in the
laboratory, previously performed a dominant genetic modifier screen using large,
overlapping chromosomal deletions and the snr1E1 allele. I analyzed the data he
generated to identify potential Brm complex coregulators in controlling gene expression.
Therefore, I determined if deficiencies removing a common functional group of
transcriptional regulators (such as acetlytransferases, demethylases, etc.) could
independently genetically interact with snr1E1, resulting in enhancement or suppression
the wing patterning phenotype associated with the snr1E1 mutation. I identified histone
lysine demethylase enzymes (KDMs) as potential mediators of Brm chromatin
remodeling activities. There are two ‘families’ of KDMs (Klose, Kallin et al. 2006;
Klose, Yamane et al. 2006; Klose, Yan et al. 2007; Swigut and Wysocka 2007). The
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Jumonji family has 12 members and is capable of demethylating tri-, di-, and
monomethylated lysine residues. A much smaller family of demethylases contains 1
member, LSD1, which is only capable of demethylating di-, and monomethylated
(H3K4) lysine residues and in mammalian cell culture analysis, di-, and monomethylated
(H3K9) lysine residues when in complexes with the Androgen Receptor or Estrogen
Receptor (AR) (Metzger, Wissmann et al. 2005). Representative deficiencies for each of
the 13 predicted histone demethylase genes exist in Drosophila (Klose, Yamane et al.
2006) and these were tested independently for a genetic interaction with snr1E1 (Fig. 12).
Deficiencies covering each of the demethylase genes were obtained and independently
crossed to snr1E1. Transheterozygotes carrying the deficiency and snr1E1 were collected
and wings examined. snr1E1/+ heterozygotes display ectopic vein material distal to the
posterior cross vein in approximately 35% of total wings examlined. Deficiencies that
when transheterozygous with snr1E1 resulted in an overall decrease in the percentage of
wings displaying an ectopic vein phenotype (0-20%) were considered to genetically
suppress the snr1E1 phenotype. An overall increase in the percentage of wings
displaying an ectopic vein phenotype (46-100%) or and increase in the severity of the
ectopic vein phenotype, such as multiple ectopic veins, was considered enhancement.
Deficiencies that when transheterozygous with snr1E1 displayed ectopic veins in 21-45%
of total wings examined were not considered to genetically interact with snr1. I found
that all 13 deficiencies tested genetically interacted; 3 deficiencies enhanced, while 10
deficiencies suppressed the snr1E1 ectopic wing vein phenotype (Table 6). To determine
if the observed genetic interactions were due to loss of the KDM gene, epistasis tests
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were performed using P-element insertion lines disrupting several predicted demethylase
genes obtained from the Exelixis and Berkeley Drosophila Genome Project (BDGP)
collections, as well as a null allele of lsd1 (lsd1∆N) (Di Stefano, Ji et al. 2007). I tested
each of these lines for a genetic interaction with snr1E1 and found that 4 Jumonji family
histone demethylase mutants, little imaginal discs (lid), CG13902, CG2982, and
CG11033 suppressed the snr1E1 ectopic vein phenotype and 2 Jumonji members, CG3654
and CG8165, enhanced the phenotype (Table 6; Fig. 12). Transposase mobilized
excision of the P-element in two of these lines, one that enhanced (CG3654EY02717) and
one that suppressed (lid2) the snr1E1 phenotype, abolished the genetic interaction
phenotype (Table 6; Fig. 12). My screen results provide a novel finding that in vivo Brm
complex chromatin remodeling functions may be highly dependent on the activity of
histone lysine demethylase enzymes.
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Figure 12: snr1E1 gentically interacts with several lysine demethylase enzymes

Figure 12 snr1 genetically interacts with histone lysine demethylase enzymes. (A)
snr1E1/+ wings display ectopic vein material distal to the PCV (arrow). (B)
Df(3L)AC1/snr1E1 transheterozygous wings have increased penetrance and expressivity of
the ectopic vein phenotype. Note ectopic vein material posterior to L5 and distal to the
PCV (arrows). (C) snr1E1/ P(CG3654)EY02717 transheterozygous wings have an enhanced
ectopic vein phenotype, with wings displaying ectopic vein material distal to the PCV
and anterior to L2 (arrows) (D) The candidate histone demethylase gene covered by the
Df(3L)AC1 deficiency, P(CG3654)EY02717, has no heterozygous wing phenotype. (E) Pelement excision from P(CG3654)EY02717 reverts the genetic interaction phenotype
observed with snr1E1. snr1E1/ P(CG3654)EY02717REV transheterozygotes have an ectopic
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vein phenotype similar to snr1E1/+ siblings (arrow) (Compare (A) to (E)). (F) The
snr1E1 transheterozygous phenotype is dominantly suppressed by Df(2L)Ed354. Note
Df(2L)Ed354/+; snr1E1/+ wings have no ectopic vein material near the PCV. (G) The
candidate histone demethylase gene covered by the Df(2L)Ed354 deficiency, lid2, has no
heterozygous wing phenotype. (H) lid2 dominantly suppresses the snr1E1 ectopic vein
phenotype. lid2/+; snr1E1/ + transheterozygotes have no ectopic veins. (I) P-element
insertion from lid2 reverts the snr1E1 phenotype. lid2REV/+; snr1E1/+ transheterozygotes
have an ectopic vein phenotype similar to snr1E1/+ siblings (arrow) (compare (A) to (I)).
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Table 6
snr1 genetically interacts with histone lysine demethylases
LSD1 (CG17149)
JHDM1 (CG11033)

JARID (LID)

JARID (CG3654)
JHDM2(CG8165)

JHDM3/JMJD2(CG15835)
JHDM3/JMJD2(CG33182)

JMJD4 (CG7200)
JMJD5 (CG13902)
JMJD5 (CG10133)
JmjC domain only (CG5383/PSR)
JmjC domain only (CG2982)

UTX/UTY (CG5640)

1

Genotype
snr1E1,e/+
snr1E1,e/Df(3L)rdgC
snr1E1,e/ P(lsd1)∆N
snr1E1,e/ Df(3R)Exel6151
snr1E1,e/ Df(ED5301)
snr1E1,e/P(CG11033)DG12810
Df(ED354)/+;snr1E1,e/+
lid1/+; snr1E1, e/+
lid2/+; snr1E1/+
lid2(REV)/+; snr1E1/+
Df(3L)AC1/snr1E1,e
snr1E1,e/CG3654EY02717
Df(3R)by10/snr1E1,e
snr1E1,e/P(CG8176)EY01319
snr1E1,e/P(CG8165)KG06456
Df(2R)Exel6055/+; snr1E1,e/+
P(CG15935)KG04636/+: snr1E1,e/+
Df(2R)Exel8057/+; snr1E1,e/+
Df(2R)CX1/+; snr1E1,e/+
P(CG33182)aats-val/+; snr1E1,e/+
Df(2L)TW137/+; snr1E1,e/+
Df(2L)Bsc149/+; snr1E1,e/+
Df(3L)ED4177/snr1E1,e
snr1E1,e/P(CG13902)e01240
snr1E1,e/Df(3L)Exel6119
snr1E1,e/P(CG10133)KG04150
snr1E1,e/Df(3R)Exel6190
snr1E1,e/P(Epgy2)EY07193
Df(1)ED6720/X; snr1E1,e/+
Df(1)ED6720/Y; snr1E1,e/+
P(CG2982)EP1316/+; snr1E1,e/+
Df(2L)Bsc206/+, snr1E1,e/+

Wings
267
105
140
94
98
180
128
144
168
60
120
152
66
116
114
50
136
94
188
136
100
118
40
138
105
78
162
86
48
48
10
142

%PCV
35
0
24
6
13
15
9
0
14
27
44
50
48
73
32
14
32
1
7
18
76
3
0
0
1
32
0
65
13
0
0
1

Enhancement, Suppression, No Effect1
Suppression (+++)
No effect
Suppression(+++)
Suppression (++)
Suppression (++)
Suppression (+++)
Suppression (+++)
Suppression (++)
No effect
Enhancement (++)2
Enhancement (++)3
Enhancement (+++)4
Enhancement (++)
No effect
Suppression (++)
No effect
Suppression (+++)
Suppression (+++)5
Suppression (++)
Enhancement (+++)
Suppression (+++)
Suppression (+++)
Suppression (+++)
Suppression (+++)
No effect
Suppression (+++)
Enhancement (++)
Suppression (++)
Suppression (+++)
Suppression (+++)
Suppression (+++)

Genetic interactions: Suppression (S)/Enhancement (E)/ No effect (NE) was scored as the percentage of
wings displaying the ectopic vein phenotype: 0-10% PCV S (+++), 11-20% PCV S (++), 21-45% NE, 4670% PCV E (++), 71-100% E (+++).
2
Tthe percentage of flies displaying the PCV phenotype was slightly higher than snr1E1/+ control flies, but
24% also have ectopic vein material posterior to L5.
3
The percentage of wings displaying the PCV phenotype was only slightly higher than snr1E1/+ sibling
controls, but 12% also have ectopic vein material anterior to L2 or posterior to L5.
4
Although the percentage of flies displaying the PCV phenotype was only slightly higher than snr1E1/+
controls, 23% of wings have a strong PCV phenotype or have ectopic vein material in wing margins.
5
The PCV phenotype was suppressed, 65% of wings are notched/serrated.
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4.8 LSD1 genetically interacts with Brm complex components. The Brm complex
has important roles in regulating gene transcription, in part by physically associating with
transcription activator proteins (Hassan, Prochasson et al. 2002) as well as RNA
Polymerase II (Armstrong, Papoulas et al. 2002), gene repressor proteins (Sudarsanam
and Winston 2000; Marenda, Zraly et al. 2004), and alternative splicing factors (Batsche,
Yaniv et al. 2006; Tyagi, Ryme et al. 2009). While much work has focused on
understanding how chromatin remodeling complexes contribute to gene activation, little
is known about how remodeling complexes function in gene repression. Therefore, I
decided to focus on the group of histone demethylase mutants that enhanced the snr1E1
wing phenotype. I reasoned that since SNR1 can function to negatively regulate Brm
complex activities in intervein cells and prevent differentiation into vein tissue (Marenda,
Zraly et al. 2004), mutations that enhanced the snr1E1 phenotype may function as
corepressors and cooperate with SNR1 to restrict specific target gene transcription.
Although the null mutant of lsd1 (lsd1∆N) showed little genetic interaction with
snr1E1, I found that lsd1∆N genetically interacted with strong loss of function alleles of
mor and brm and snr1 (Table 7). The lsd1∆N mutation removes the presumptive lsd1
promoter and N-terminal region, including the SWIRM domain (Di Stefano, Ji et al.
2007). Homozygous lsd1∆N flies have reduced viability and are sterile, with limited
impact on overall development. The wings of heterozygous lsd1∆N/+ flies appear normal
(Fig. 13A), and snr1E1/lsd1∆N animals show no change in penetrance or expressivity of
the snr1E1 ectopic vein phenotype (Fig. 13B,C). The wings of brm2 heterozygotes also
appear normal (Fig. 13D), but doubly heterozygous lsd1∆N/brm2 wings display ectopic
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vein material distal to the PCV (Fig. 13E). It was previously demonstrated that a
heterozygous brm2 mutation suppressed the ectopic vein phenotype associated with
heterozygous snr1E1 (Marenda, Zraly et al. 2003). Therefore, I predicted that the ectopic
vein phenotype observed in lsd1∆N/brm2 animals would be suppressed by additional
heterozygous mutation of snr1E1. Interestingly, the ectopic vein phenotype observed in
lsd1∆N/brm2 wings was further enhanced by the snr1E1 allele (Fig. 13F,G). The lsd1∆N
allele also demonstrated strong allele-specific interaction with various mor mutants (Fig.
13, Table 7). For example, the double heterozygous combination of lsd1∆N with mor1, a
loss of function point mutation (Fig. 13H), leads to the appearance of ectopic posterior
crossveins by more than 50% (Fig. 13I). These data suggest that LSD1 might directly
contribute to the repression functions of the Brm complex in wing intervein cells.
4.9 LSD1 associates with Brm complexes containing POLYBROMO/BAP180 and
BAP170 (PBAP) but not OSA (BAP). The SWI/SNF family of remodeling complexes
can be divided into two subclasses that have the same constellation of core subunits, with
differences in signature subunit composition (Mohrmann and Verrijzer 2005). In
Drosophila, BAP complexes contain OSA as a signature subunit while PBAP complexes
contain POLYBROMO/BAP180, BAP170 and SAYP but not OSA (Collins and
Treisman 2000; Mohrmann, Langenberg et al. 2004; Moshkin, Mohrmann et al. 2007;
Chalkley, Moshkin et al. 2008). Genetic studies have revealed pathway-specific
regulation of target genes by each of these Brm complex subclasses. Therefore, I tested
if lsd1∆N displayed a preferential genetic interaction with mutations in osa, polybromo
(Bap180), or Bap170. I observed no genetic interaction (Fig. 13K) between lsd1∆N and a
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loss of function osa mutant (osa00090) (Treisman, Luk et al. 1997; Vazquez, Moore et al.
1999; Marenda, Zraly et al. 2004) in the context of wing pattern development. However,
lsd1∆N interacted strongly with null alleles Bap180∆86 and Bap170∆65 (Fig. 13L-O, Table
7), suggesting that LSD1 corepressor functions may be targeted to PBAP-specific wing
development pathways.
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Figure 13: LSD1 genetically interacts with PBAP but not BAP complexes
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Figure 13: LSD1 genetically interacts with PBAP but not BAP complexes. (A)
lsd1∆N heterozygotes have normal wings. (B)Dominant negative point mutant, snr1E1/+
wings display ectopic vein material distal to the PCV (arrow). (C) lsd1∆N shows no
genetic interaction with snr1E1. snr1E1/ lsd1∆N transheterozygotes have wings similar to
snr1E1/+ animals (arrow) (compare (B) and (C)). (D) Animals heterozygous for the null
allele brm2 have normal wings. (E) lsd1∆N genetically interacts with brm2. lsd1∆N /brm2
transheterozygotes have ectopic vein material distal to the PCV (arrow) (compare (D) and
(E)). (F) brm2 dominantly suppresses the snr1E1 ectopic vein phenotype (compare (B)
and (F)). (G) brm2, snr1E1/ lsd1∆N transheterozygotes show ectopic vein material
posterior to L5 (arrow). (H) Animals heterozygous for the point mutant allele, mor1,
have normal wings. (I) lsd1∆N genetically interacts with mor1 (compare (H) and (I).
lsd1∆N / mor1 transheterozygotes have ectopic vein material posterior to L5 and distal to
the PCV (arrows). (J) Wings from animals carrying a P-element insertion in the 5’UTR
of the osa gene, osa osa00090/+, appear normal. (K) No genetic interaction observed
between lsd1∆N and osa00090 (compare (J) and (K)), as wings appear normal in lsd1∆N
/osa00090 transheterozygotes. (L) Animals heterozygous for the null allele, Bap180∆86,
have normal wings. (M) Bap180∆86 genetically interacts with lsd1∆N (compare (L) and
(M)). Bap180∆86/ lsd1∆N transheterozygous wings have ectopic vein material distal to the
PCV (arrow). (N) Animals heterozygous for the null allele, Bap170∆65, have wings that
appear normal. (O) Bap170∆65 genetically interacts with lsd1∆N (compare (N) and (O))
lsd1∆N/Bap170∆65 transheterozygous wings have ectopic vein material distal to the PCV
(arrow)
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Table 7
lsd1 genetically interacts with mutations in PBAP but not BAP remodeling complexes
Genotype
lsd1∆N/+
mor1/+
mor1/ lsd1∆N
mor2/+
mor2/ lsd1∆N
mor3/+
mor3/ lsd1∆N
mor4/+
mor4/ lsd1∆N
mor5/+
mor5/ lsd1∆N
mor6/+
mor6/ lsd1∆N
brm2/+
brm2/ lsd1∆N
snr1R3/+
snr1R3/ lsd1∆N
osa00090/+
osa00090/ lsd1∆N
polybromoEY14080/+
polybromoEY14080/ lsd1∆N
polybromoEY14730/+
polybromoEY14730/ lsd1∆N
bap180∆86/+
bap180∆86/ lsd1∆N
bap170∆65/+
bap170∆65/ lsd1∆N
1.

# wings
152
152
188
267
135
319
104
106
117
130
192
241
100
134
170
90
148
70
74
81
127
28
36
96
101
114
96

% ectopic
1
5
57
0
3
52
100
0
6
34
11
44
61
3
14
0
9
0
5
31
50
50
81
0
18
2
39

Genetic Interaction1
Enhancement (+++)
No Effect
Enhancement (+++)
No Effect
Suppression
Enhancement (++)
Enhancement (+)
Enhancement (+)
No Effect
Enhancement (++)
Enhancement (++)
Enhancement (++)
Enhancement (++)

Genetic enhancement or suppression was classified based on changes in either expressivity (the degree of
ectopic vein material present) or penetrance (changes in the percentage of wings displaying the ectopic vein
phenotype). I scored mild enhancement (+) as an approximate 10-20% increase in penetrance, moderate
enhancement (++) as 15-40% increase in penetrance, and strong enhancement (+++) as greater than 45%
enhancement.
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4.10

SNR1 does not physically interact with other SWIRM domains LSD1 is not a

component of purified Brm complexes (Papoulas, Beek et al. 1998); therefore, the
observed genetic epistasis results might reflect either direct or indirect interaction.
Collaborative efforts with Dr. Claudia Zraly were used to address whether LSD1 could
physically associate with the Brm complex by using in vivo coimmunoprecipitation and
GST-pulldown assays. These analyses demonstrated that the N-terminal portion of
LSD1, containing the SWIRM domain, physically associated with the Brm complex
(Curtis et. al 2010 in preparation). There are only three known SWIRM-containing
proteins in Drosophila, all of which are involved in chromatin regulation (Da, Lenkart et
al. 2006; Yoneyama, Tochio et al. 2007). In addition to MOR and LSD1, the
SAGA/GCN5 histone acetyltransferase complex adaptor protein ADA2 contains a
similarly conserved SWIRM domain. ADA2 is known to function in transcription
activation in cooperation with the yeast SWI/SNF complex (Pollard and Peterson 1997),
and it was recently shown to play an important role in gene silencing (Jacobson and
Pillus 2009). I earlier demonstrated that SNR1 interacted with MOR through a SWIRM
domain; therefore, I predicted that LSD1 would most likely interact with SNR1. To
address this possibility, I employed yeast 2-hybrid analyses using the LexA DNA binding
domain fusions to LSD1, including one that contained the N-terminal portion of LSD1
(aa1-255) and one that contained the C-terminal portion (aa258-876) to serve as a
negative control. As a positive control, I generated a LexA:MOR (SWIRM) fusion that is
known to interact with SNR1 (www.pimrider.com). I also created a LexA:ADA2 fusion
that only contained the ADA2 SWIRM. These 4 constructs were tested against B42
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4.11

Activation Domain (AD) fusions to SNR1. I found the C- portion of SNR1,

containing the R2 and CC regions only interacted with the SWIRM domain of MOR, but
not LSD1 or ADA2. Therefore, SNR1 does not physically associate with other SWIRM
containing proteins and the SNR1-MOR SWIRM interaction is specific, suggesting that
the interaction observed between the Brm complex and LSD1 is likely mediated by
another subunit.
TABLE 8
The SNR1-MOR SWIRM interaction is specific
LexA(DB) fusions
Construct
Amino acids
MOR SWIRM
442-552
ADA2A SWIRM 477-530
LSD1 N-term
1-253

1.

B42(AD)fusions
Construct
Amino acids LacZ activity1
SNR1 FL
15-370
++
SNR1 FL
15-370
SNR1 FL
15-370
-

SNR1 does not physically interact with other SWIRM domains in yeast 2-hybrid analyses. SNR1
(15-370)-B42 Activation Domain (AD) fusion proteins were tested for physical interaction with
MORSWIRM (442-552)-LexA, ADA2A-SWIRM (477-530)-LexA, and LSD1-Nterm (1-253)-LexADNA Binding Domain (DBD) fusions in yeast 2-hybrid analyses. Protein-protein interactions were
assessed by the production of β-galactosidase (blue colony formation) and, independently, growth on media
lacking leucine.
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4.11 LSD1 has an important role in wing development. LSD1 exhibits both genetic
and protein interaction with components of the Brm chromatin remodeling complex,
suggesting that LSD1 might have an important role in wing pattern formation in
cooperation with Brm functions. I previously found that the Brm complex is widely
expressed in wing tissues during the early pupal stage that corresponds to the
developmental period when the cross veins are forming (Marenda, Zraly et al. 2004).
Similarly, LSD1 is expressed uniformly throughout the developing pupal wing, in both
vein and intervein cells (Figure 14 A,B) which is consistent with a broad role in
regulating the expression of genes required for proper wing vein development. However,
examination of loss of function lsd1 mutants has not revealed direct links to defects in
wing patterning (Di Stefano, Ji et al. 2007; Rudolph, Yonezawa et al. 2007).
In order to better understand the relationship between LSD1 and the Brm
complex, I employed a tissue-specific knockdown of lsd1 in the developing wing using
the GAL4-UAS system (Bernstein, Caudy et al. 2001; Dietzl, Chen et al. 2007). Short
hairpin-RNAi (shRNAi) constructs, also known as inverted repeats (IR), were expressed
in a tissue specific manner to deplete lsd1 mRNA. Expression of an lsd1-IR using the
GawB69B GAL4 imaginal disc driver led to ectopic veins anterior to the L2 longitudinal
vein and along the posterior crossvein (Fig. 14C), a phenotype similar to the effects of
losing Brm complex repressor functions. The penetrance and expressivity of the
knockdown phenotype was greater in males as well as flies reared at 29°C, and enhanced
by the addition of a UAS-Dicer transgene that amplifies the RNAi effect (Bernstein,
Caudy et al. 2001; Dietzl, Chen et al. 2007). UAS-Dicer; lsd1-IR/GawB69B males
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displayed the strongest phenotypes including crumpled, broken and held-out wings (Fig.
14B and data not shown).
Wing veins develop as a consequence of specific signaling pathways that restrict
vein development to specific subsets of cells within the wing primordium (Mohler,
Seecoomar et al. 2000). The Brm complex contributes to the development of the veins
through activation functions in vein cells and suppression of those pathways in the
developing intervein cells (Marenda, Zraly et al. 2004). To help determine whether LSD1
cooperates in restricting vein development, I expressed the lsd1-IR in wing intervein cells
through the use of a blistered-GAL4 driver. Blistered (BS) is homologous to mammalian
serum response factor and the expression of BS is restricted to intervein cells in the
developing Drosophila wing (Johannes and Preiss 2002). I found that loss of lsd1 in
intervein cells resulted in ectopic vein formation including an ectopic anterior cross vein
(ACV) in a small percentage of animals (Fig. 14E). This data supports the hypothesis
that LSD1 functions to repress wing vein formation in intervein cells, possibly by
cooperating with the Brm complex to restrict vein-specific gene transcription.
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Figure 14: LSD1 has an important role in wing development

Figure 14: LSD1 has an important role in wing development.
Immunohistochemical analysis using wild-type pupal wings from Stage P7 (34-50 hr
APF) (Bainbridge and Bownes 1981) animals and anti-LSD1 antibodies. (A and B)
LSD1 is expressed in both vein and intervein cells. (A) No antibody negative control.
(B) LSD1 is present throughout the entire pupal wing. (inset) Higher magnification
demonstrates LSD1 is present in both vein and intervein cells. Staining experiments were
performed twice, with approximately 10 wings examined per sample per experiment (CE)

The GAL4-UAS system was utilized to express short-hairpin RNAi (shRNAi)

constructs in a cell type or developmental time-specific manner. The GawB69B driver
leads to GAL4 expression in larval imaginal discs. The blistered driver (bs-GAL4) leads
to GAL4 expression specific to wing intervein cells during pupal development. All
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knockdown experiments were carried out at 29° C. (C) Expression of shRNAi-LSD1
using GawB69B causes ectopic vein development (arrows). (D) This effect is enhanced
by overexpressing Dicer (UAS-Dicer), an essential part of cellular RNAi machinery. (E)
Expression of shRNAi-LSD1 using bs-GAL4 leads to the formation of an ectopic ACV
in a small percentage of flies.

4.12 dCoREST has an important role in wing development

In mammals, the ability of LSD1 to demethylate lysine substrates is dependent upon its
physical association with an accessory protein, CoREST (Lee, Wynder et al. 2005). A
complex containing dLSD1, dCoREST, and TTK69 or TTK88 has been observed in
Drosophila (Dallman, Allopenna et al. 2004). Very little is known about the role of
dCoREST in normal development, or whether the enzymatic activity of dLSD1 is
dependent upon its association with dCoREST, as was observed in mammals. To
determine if dCoREST has an important role in wing patterning and development, I used
the UAS/GAL4 system to knock-down CoREST by overexpressing dCoREST-IR-shRNAi
(CoREST-IR) transgenes at a specific time and tissue during development. Similar to the
results obtained upon knocking down dlsd1 the knock-down of dCoREST also resulted in
ectopic vein phenotypes. However, my data indicates that the ectopic vein phenotypes
observed with dCoREST-IR are highly sensitive to the extent of knockdown. Therefore,
wings of dCoREST-IR, GawB69B, rholacZX81/+ animals appear normal when reared at
25°C, but have significant ectopic vein phenotypes surrounding both the ACV and PCV,
anterior to L2, and at the distal margin when raised at 29°C (Figure 15 A,B). This is
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likely because GAL4 expression is increased with increasing temperatures, resulting in an
enhanced knock-down.

Increasing the efficacy of knockdown by overexpressing Dicer

(UAS-Dicer) also leads to ectopic vein formation in dCoREST-IR, GawB69B,
rholacZX81/+ reared at 25°C (Figure 15C). Animals that carry two copies of the
dCoREST-IR transgene, dCoREST-IR, GawB69B, rholacZX81/ dCorest-IR have the most
severe phenotype, with wings displaying a bifurcated PCV as well as ectopic vein
material at the distal margin (Figure 15D). The bsGAL4 driver was used to specifically
express dCoREST-IR in intervein cells. dCoREST-IR/ bsGAL4,rholacZX81 wings display
ectopic vein material anterior to L2 (Figure 15E), suggesting that dCoREST serves to
repress vein cell differentiation in intervein cells during pupal wing development.
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Figure 15: dCoREST negatively regulates vein cell differentiation in intervein cells

Figure 15: The ectopic vein phenotype observed when the GAL4/UAS system was
utilized to express dCoREST-shRNAi (dCOREST-IR) constructs in developing wings
is highly sensitive to degree of knockdown. (A) The wings of dCoREST-IR, GawB69B,
rho-lacZX81 /+ wings appear normal at 25°C. (B) dCoREST-IR, GawB69B, rho-lacZX81 /+
wings have ectopic vein material when flies are reared at 29°C (arrows). (C)
UASDicer/+; dCoREST-IR, GawB69B, rho-lacZX81 /+ 25°C wings display ectopic vein
material (arrows). (D) dCoREST-IR/ dCoREST-IR, GawB69B, rho-lacZX81 25°C wings
display strong ectopic vein phenotypes as well as branching of the PCV (arrows). (E)
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bsGAL4 expression is limited to intervein cells in developing pupal wings. dCoRESTIR/bsGAL4, rho-lacZX81 wings display ectopic vein material anterior to the PCV (arrow).
4.13 Tramtrack69 and Tramtrack88 have opposite roles in wing development
It has been demonstrated that dLSD1 and dCoREST exist in complex with either TTK69
and/or TTK88 and Rpd3 (the HDAC1/2 homolog in Drosophila) (Dallman, Allopenna et
al. 2004). Therefore, I expressed UAS-ttk-shRNAi (UAS-ttk-IR) constructs with a wing
specific GAL4 driver to determine if ttk has an important role in wing development. The
UAS-ttk-IR transgene is predicted to decrease both TTK69 and TTK88 expression. I
observed that knockdown of both ttk69 and ttk88 in larval wing discs (C765-GAL4)
resulted in the formation of ectopic vein material distal to the PCV (Figure 16A). Ectopic
vein material was also observed when ttk-IR was specifically knocked down in intervein
cells (bsGAL4), suggesting that ttk69 and/or ttk88 may have a negative role to repress
vein cell differentiation, similar to the roles observed with dCoREST-IR and dlsd1-IR
(Figure 16B). To address the independent roles of TTK69 and TTK88 in wing
development, I obtained UAS-ttk69 and UAS-ttk88 transgenes from the Bloomington
Drosophila Stock Center. In combination with a GAL4 driver, these transgenes will lead
to overexpression of ttk69 or ttk88. Therefore, if these genes are important for
repressing vein cell differentiation, I would predict that overexpression in larval imaginal
discs should either result in no phenotype or a loss of vein phenotype. Overexpression of
ttk88 with the UAS-ttk88 transgene resulted in formation of ectopic vein material distal to
the PCV (Figure 16C). Further, UAS-ttk88 expression limited to intervein cells (bsGAL4)
also resulted in formation of ectopic vein material (Figure 16D). These data suggest that
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ttk88 may have a positive role to promote vein cell differentiation. Animal viability is
highly sensitive to ttk69 levels, as UAS-ttk69 overexpression using various GAL4 drivers
was lethal, even at lowered temperatures (Figure 16E). However, when overexpression
was limited to intervein cells using the bsGAL4 driver, two escapers survived, and each
had 1 wing with an incomplete PCV (Figure 16F). These data suggest that TTK88 and
TTK69 have opposing roles in wing development. TTK69 may function to repress vein
development, whereas TTK88 may have a positive role to promote vein development.
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Figure 16: TTK69 and TTk88 have opposing roles in wing development

Figure 16: TTK69 and TTK88 has opposing roles in wing development
The GAL4/UAS system was utilized to express UAS-ttk-IR, which decreases both ttk69
and ttk88 levels, and UAS-ttk69 or UAS-ttk88, which overexpress ttk69 and ttk88
respectively. (A) Loss of both ttk69 and ttk88 throughout the wing imaginal disc leads to
the formation of ectopic vein material. ttk-IR/+ ;C765-GAL4/+ wings have ectopic vein
material distal to the PCV (arrow). (B) Loss of ttk69 and ttk88 in intervein cells leads to
the formation of ectopic vein material. ttk-IR/bsGAL4 wings display ectopic vein
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material anterior to L2 (arrow). (C) Overexpression of ttk88 throughout the wing
imaginal disc leads to the formation of ectopic vein material. UAS-ttk88/+;
C765GAL4/+ wings show extra vein material distal to the PCV (arrow). (D)
Overexpression of ttk88 limited to intervein space leads to ectopic vein formation.
UAS-ttk88/+; bsGAL4/+ wings have ectopic vein material distal to the PCV (arrow). (E)
Overexpression of ttk69 with UASttk69 in wing imaginal discs is lethal. (F)
Overexpression of ttk69 limited to intervein space leads to vein loss. UAS-ttk69/bsGAL4
wings show an incomplete PCV phenotype (arrow).

4.14 dLSD1 and dCoREST are negative regulators of wing development
Homozygous loss of function mutations in factors that negatively regulate vein
development often result in the formation of ectopic vein material, as was observed in
dCoREST and dlsd1 knockdown experiments. Formation of ectopic vein material in
these assays also implies that Egfr and/or Dpp signaling is regulated by dCoREST and
dlsd1. Heterozygous mutation in Egfr or Dpp signaling components often results in
normal wing phenotypes. However, transheterozygous mutations in multiple negative
regulators can result in ectopic vein formation. To determine if dLSD1 and dCoREST
are negative regulators of wing development, genetic epistasis experiments were
performed using a hypomorphic (loss of function) allele in a known negative regulator of
vein cell development, argos.
Argos is an Egfr ligand involved in an inhibitory feedback loop to restrict vein
cell differentiation to the developing proveins (Schweitzer, Howes et al. 1995;
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Sawamoto, Okabe et al. 1996). The argosw11 allele is a transposon insertion within the 5’
regulatory region of argos. Heterozygous argosw11/+ flies have normal wings (Figure
17A). Since argos is a known negative regulator of vein development, transheterozygous
mutation of a second negative regulator should lead to the development of ectopic veins.
Therefore, I hypothesized that argosw11/dlsd1∆N or dCoRESTEY14216 /; argosw11/+ animals
would have ectopic vein material. As predicted, I observed that argosw11/dlsd1∆N and
dCoRESTEY14216 /; argosw11/+display strong ectopic vein phenotypes (Figure 17 B,C).
However, ttk1/argosw11 transheterozygotes wings appear normal (Figure 17D). This data
suggest that dLSD1 and dCoREST likely negatively regulate vein cell development. The
lack of a genetic interaction with ttk1 may be the result of the nature of the allele, since
ttk1 is a TTK88 loss of function/ TTK69 gain of function allele. Further genetic epistasis
experiments with ttk alleles specific to either ttk69 or ttk88 are required to further define
the role of these genes in wing development.
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Figure 17: dlsd1 and dCoREST genetically interact with argos

Figure 17: dlsd1∆N and dCoRESTEY14216 genetically interact with argosw11 (A) Wings
from argosw11/+ heterozygotes appear normal. (B) dlsd1∆N genetically interacts with
argosw11. dlsd1∆N /argosw11 transheterozygotes display ectopic vein material posterior to
L5 and distal to the PCV. (C) dCoRESTEY14216 genetically interacts with argosw11.
dCoRESTEY14216/+; argosw11/+ animals have ectopic vein material distal to the PCV and
posterior to L5, as well as at the distal edge of longitudinal wing veins L4 and L5. (D)
ttk1 does not genetically interact with argosw11. The wings of ttk1/ argosw11
transheterozygotes appear normal.
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4.15 dCoRESTEY14216 and ttk1 genetically interact with rhove-1, a downstream Egfr
and Dpp signaling component
The ectopic vein phenotypes observed with dCoREST and dlsd1 knockdown implicate
Egfr and/or Dpp signaling is misregulated. In order to determine the pathway(s) that are
regulated by dLSD1 and dCoREST, a series of genetic epistasis experiments were carried
out. Rho is a serine protease essential for processing of the main Egfr ligand, Spitz, to
promote vein cell differentiation and maintenance in wing development. rhomboid (rho)
can be considered both an upstream and downstream target of Egfr and Dpp signaling.
This is because activation of Egfr/Dpp signaling directly results in transcription of rho,
making rho downstream of Egfr binding. Rho in turn processes Spitz, which is then
released into the cytosol, where it activates Egfr signaling in adjacent cells, and putting
Rho upstream of Egfr signaling. Animals homozygous for rhove-1, a loss of function
allele, have truncated longitudinal wing veins L2-L5 with 100% penetrance (Figure 18).
The degree of L2-L4 shortening varies. However, the L5 wing vein extends to the PCV in
80% of wings examined with 20% displaying an L5 vein that ends proximal to the PCV.
Therefore, the rhove-1 phenotype can be both enhanced, by increasing the percentage of
animals displaying a shortened L5 that truncates before reaching the PCV, and
suppressed, when the percentage of animals displaying the shortened L5 phenotype is
decreased or when L5 extends distal to the PCV. Loss of function mutations in factors
that promote vein development should enhance the rhove-1 phenotype, whereas mutations
in negative regulators should suppress the phenotype. I hypothesized that dlsd1∆N and
dCoRESTEY14216 would suppress the rhove-1 phenotype. I determined if dlsd1∆ N/+;
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dCoRESTEY14216/ dCoRESTEY14216, or ttk1/+could genetically interact with homozygous
rhove-1. dlsd1∆ N /+did not genetically interact with rhove-1. However, dCoRESTEY14216/
dCoRESTEY14216; rhove-1/rhove-1 animals displayed wings with L5 veins that extended
distal to the PCV, demonstrating suppression of the rhove-1 phenotype, and supporting my
hypothesis that dCoREST is a negative regulator of wing vein development. An opposite
genetic interaction was observed with ttk1, rhove-1/rhove-1 animals. ttk1/+ enhanced the
homozygous rhove-1 phenotype, causing an increase in the number of wings with an L5
vein that truncated proximal to the PCV. (Figure 18)
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Figure 18: dCoRESTEY14216 and ttk1 heterozygotes display opposite genetic
interactions with rhove-1

Figure 18: A genetic interaction is observed between dCoRESTEY14216/
dCoRESTEY14216, ttk1/+, and rhove-1/ rhove-1. (A) rhove-1 homozygotes display a shortened
wing vein phenotype. (B) Heterozygous lsd1∆N does not genetically interact with rhove-1.
No difference in L5 length is observed when rhove-1, lsd1∆N / rhove-1 wings are compared
to rhove-1 / rhove-1 alone (compare (A) and (B)). (C) Homozygous dCoRESTEY14216
suppresses the rhove-1 phenotype. The L5 vein extends distal to the PCV in
dCoRESTEY14216; rhove-1 wings (arrow). (D) Heterozygous ttk1 enhances the rhove-1
phenotype. The L5 wing vein does not extend to the PCV in ttk1, rhove-1 / rhove-1 animals
(arrow).
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4.16 Tissue specific knockdown experiments suggest dLSD1/dCoREST negatively
regulate rhomboid transcription Genetic interactions between dCoRESTEY14216 and
rhove-1 suggest that dCoREST may have an important role in regulating rho transcription
during pupal wing development. To address this question, recombinant stocks were built
that carried the GawB69B GAL4 driver and the rho-lacZX81 enhancer trap line
(GawB69B, rho-lacZX81/TM6B). Triple recombinants were further generated that carried
CoREST-IR, GawB69B, rho-lacZX81/TM6. All recombinants were verified using primers
specific to LacZ, GAL4, and the CoREST-IR shRNAi construct in single-fly PCR. It was
previously demonstrated that rho-lacZX81 staining is localized to provein cells in wildtype pupal wings (Marenda, Zraly et al. 2004). I first verified the GawB69B, rholacZX81/+ pupal wings have a normal pattern, with LacZ staining localized to provein
cells (Fig. 19A). Next, I determined if knockdown of LSD1 caused rholacZX81
misexpression, and observed that UAS-Dicer/+; LSD1-IR/GawB69B, rho-lacZX81 wings
also appear normal (Fig. 19B). To examine the effect of dCoREST knockdown, I
examined pupal wings from UAS-Dicer/+; CoREST-IR/GawB69B, rho-lacZX81 animals
and observed ectopic expression of rho-lacZX81 distal to the PCV (Fig. 19C). Lastly,
tested whether knock-down of both dLSD1 and dCoRESTEY14216 could enhance ectopic
rho-lacZX81 expression. I observed pupal wings from UAS-Dicer/+; CoREST-IR,
GawB69B, rholacZX81/LSD1-IR animals and saw strong ectopic rho-lacZX81 staining
around the PCV, as well as a thickened L3 provein (Fig. 19D). These results indicate that
dCoREST functions to repress rho expression in intervein cells and suggests that dLSD1
may contribute to dCoREST-mediated repression. Further, transcription of rhomboid can
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result from activation of both Egfr and Dpp signaling, implying that dCoREST and
dLSD1 may regulate either or both signaling pathways.
Figure 19: Knockdown of dCoREST and dlsd1 causes ectopic rho-lacZX81 staining

Figure 19: Knockdown of dCoREST and dlsd1 leads to ectopic rho-lacZX81 staining
(A) GawB69B, rho-lacZX81/+ control animals. rho-lacZX81 staining is confined to
proveins L2-L5, ACV, PCV and the wing margin. (B) UAS-Dicer/+; Lsd1-IR/GawB69B,
rho-lacZX81 staining appears similar to control siblings. (C) UAS-Dicer/+; CoREST-IR/
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GawB69B, rho-lacZX81 pupal wings display ectopic rho-lacZX81 staining distal to the
PCV. (D) UAS-Dicer/+; CoREST-IR, GawB69B, rho-lacZX81/Lsd1-IR pupal wings have
ectopic rho-lacZX81 staining near the PCV as well as slight thickening of L3. The right
column is higher magnification of the left panel.
4.17 Genetic epistasis experiments suggest dLSD1/dCoREST does not regulate
Egfr signaling Data from knock-down and genetic epistasis experiments suggest that
dLSD1 and dCoREST are likely regulating Egfr and/or Dpp signaling. My next goal was
to determine if Egfr, Dpp, or both Egfr and Dpp are regulated by dLSD1/dCoREST. To
address this question, I carried out a series of genetic epistasis experiments using the
dCoRESTEY14216 and dlsd1∆N alleles. I first determined if transheterozygous combinations
with various mutations in Egfr signaling components and either dCoRESTEY14216 or
dlsd1∆N led to wing patterning defects. I observed no genetic interactions with upstream
Egfr signaling pathway mutants, including mutations in the Egfr receptor, EgfrE1p, and
downstream effector rolled, rl1. No genetic interaction was observed with downstream
Egfr signaling components, such as the transcription factor Pointed and Egfr ligand, vein.
These data suggest that the ectopic vein phenotypes observed with dLSD1 and dCoREST
knockdown is likely the result of misregulated dpp, but not Egfr, signaling.
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TABLE 9
dCoRESTEY14216 and lsd1∆N do not genetically interact with Egfr signaling
components

%
%
%
Total
Mult.
inc.
ectopic
Ect
vein
Egfr
EgfrE1p/+
128
100
0
dCoREST EY14216/+;EgfrE1p/+
74
98
0
EgfrE1p/+; lsd1∆N /+
60
95
0
Rolled
rl1/+
126
2
0
0
rl1/+; lsd1∆N /+
0
0
0
0
rlSEM/+
106
100
0
dCoREST EY14216/+; rlSEM/+
24
100
0
rlSEM/+; lsd1∆N /+
92
100
0
Pointed
pnt1277/+
180
0
0
0
dCoREST EY14216/+; pnt1277/+
68
0
0
0
pnt1277/ lsd1∆N
100
9
0
0
c221
vn /+
Vein
99
0
0
0
EY14216
c221
dCoREST
/-; vn /+
52
2
0
0
∆N
c221
lsd1 / vn
68
13
0
0
EY14216
1
dCoREST
/-; ci /+
67
67
0
0
1.
Any transheterozygous combination that led to the development of ectopic veins was considered a genetic
interaction.
Signaling component

Genotype

No.
wings

Genetic
1
interaction

N
N
N
N
N
N
Y(weak)
N
Y
Y
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4.18 dLSD1/dCoREST genetically interact with mutations in dpp regulatory
regions. I next wanted to determine if dCoRESTEY14216 and dlsd1∆N could genetically
interact with transheterozygous mutations in Dpp signaling pathway components. Dpp
signaling is initiated by binding of the Dpp ligand to heterodimeric receptor complexes,
consisting of either THICKVEINS/SAXOPHONE or THICKVEINS/PUNT. I first
looked to see if recessive mutations in dpp regulatory regions (dpps1 and dpps1,dppdh-o),
which affect dpp expression, genetically interacted with dlsd1∆N and dCoRESTEY14216.
dpp expression is governed by extensive 3’ and 5’ regulatory regions. The 3’-disk
regulatory region regulates dpp expression during larval development, whereas the 5’-shv
regulatory region regulates expression during pupal development (Segal and Gelbart
1985). Two dpp alleles were used. The dpps1 mutation is located within the 5’ shortvein
regulatory region, where dpp expression is downregulated during pupal development. I
assessed whether dCoRESTEY14216 and dlsd∆N could genetically interact with dpps1 by
looking for changes in the percentage of wings showing an ectopic vein phenotype, a loss
of vein phenotype, or an incomplete PCV phenotype. Homozygous dpps1 mutation
results in shortening of L4, incomplete PCV formation, as well as ectopic vein
development (Figure 20A). I found that both dCoRESTEY14216 and dlsd∆N genetically
interacted with dpps1. The ectopic vein phenotype is enhanced by heterozygous dlsd1∆N
and heterozygous dCoRESTEY14216 mutation, while the incomplete PCV phenotype is
suppressed (Figure 20B,C). The dppdh-o allele is a recessive mutation within the 3’ disk
regulatory region, and affects dpp expression during larval stages of development
(Blackman, Sanicola et al. 1991). dpps1,dppdh-o wings have more severe phenotypes, such
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as shortening of L2 and L4, incomplete PCV formation, as well as ectopic vein
development (Figure 20D). Heterozygous dlsd1∆N and heterozygous dCoRESTEY14216
mutation both genetically interact with dpps1,dppdh-o, leading to an enhancement of the
ectopic vein and incomplete PCV phenotype and suppression of the L2 shortening
phenotype. A fully recessive mutation in the 3’ disk regulatory region, dppd14,
genetically interacted with dlsd1∆N, but not dCoRESTEY14216, resulting in development of
ectopic vein material in dppd14/+; lsd1∆N/ + transheterozygotes (data not shown). These
data suggest that dCoREST and dLSD1 contribute to wing development by regulating
Dpp signaling.
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Figure 20: dlsd1∆N and dCoRESTEY14216 genetically interact with dpps1 and dpps1,dppdh-

o

Figure 20: dlsd1∆N and dCoRESTEY14216 genetically interact with dpps1 and
dpps1,dppdh-o (A) Wings from dpps1/dpps1 animals have an incomplete PCV phenotype
(arrow), shortening of L4 (arrow), and multiple ectopic veins (arrows). (B) Heterozygous
dCoRESTEY14216 mutation suppresses the incomplete PCV phenotype and enhances the
ectopic vein phenotype. dCoRESTEY14216 /+ ; dpps1/dpps1 wings have normal PCV
development, but have more severe ectopic veins than dpps1/dpps1 alone (arrows). (C)
Heterozygous dlsd1∆N mutation suppresses the incomplete PCV phenotype and enhances
the ectopic vein phenotype. dlsd1∆N /+ ; dpps1/dpps1 wings have a normal PCV, but
display more severe ectopic vein phenotypes than dpps1/dpps1 alone (arrows). (D)
Homozygous dpps1, dppdh-o mutation leads to L2 and L4 vein shortening (arrows),
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incomplete PCV development (arrow), and the formation of ectopic veins (arrows). (E)
Heterozygous dCoRESTEY14216 genetically interacts with homozygous dpps1, dppdh-o,
enhancing the ectopic vein and incomplete PCV phenotypes (arrows), and suppressing L2
shortening. (F) Heterozygous dlsd1∆N genetically interacts with homozygous dpps1,
dppdh-o, enhancing the ectopic vein phenotype and incomplete PCV development
(arrows), and suppressing L2 shortening.

4.19 Genetic epistasis experiments suggest dLSD1/dCoREST negatively regulate
Dpp signaling. The Dpp signaling pathway involves many signaling molecules. To
better understand where dCoREST and dLSD1 contribute to Dpp signaling, a series of
genetic epistasis experiments were performed. Since genetic interactions were observed
with mutations that presumably affect expression of the Dpp ligand, I performed a series
of genetic epistasis experiments looking for transheterozygous wing patterning
phenotypes associated with loss of function mutations in downstream Dpp signaling
components and the dlsd1∆N or dCoRESTEY14216 loss of function alleles (Table 10, Figure
21). Binding of the Dpp ligand to TKV-PUNT receptor heterodimers results in
serine/threonine phosphorylation of TKV by the constituitively active PUNT receptor.
The phosphorylated TKV receptor, in turn, phosphorylates and activates the only receptor
cytoplasmic transducer in Drosophila, Mothers against Dpp (MAD). Once
phosphorylated, p-MAD forms a complex with MEDEA. The multiprotein complex is
then translocated into the nucleus where it directly regulates the transcription of two main
targets within the spalt gene complex, sal and salr (Doctor, Jackson et al. 1992;
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Kuhnlein, Frommer et al. 1994; de Celis, Barrio et al. 1996). The spalt gene complex
contributes to the development of L2, by regulating expression of the transcription factor
knirps (knr) and knirps-related (knrl), and in L5 by regulating expression of the
transcription factors of Iroquois-complex (Iro-C), which include araucan (ara),
caupolican (caup), and mirror (mirr) Gomez-Skarmeta, 1996 #288} (Micchelli, Rulifson
et al. 1997). I obtained loss of function mutations in these downstream Dpp signaling
components and tested for genetic interaction with dlsd1∆N or dCoRESTEY14216. I
observed strong genetic interactions between several signaling components and dlsd1∆N
or dCoRESTEY14216, suggesting a role for dLSD1/dCoREST in regulating genes involved
in Dpp signaling (Table 10, Figure 21).
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Table 10: dCoRESTEY14216 and lsd1∆N genetically interact with Dpp signaling components

Signaling component
Dpp pathway
thick veins
dally

mad

medea

mirror

E(spl)mβ
knot
salm

plexus

knirps

brinker

araucan
omb

caupolican

Genotype
7

tkv /+
EY14216
7
dCoREST
/+; tkv /+
06464
dally
/+
EY14216
06464
dCoREST
/+; dally
/+
∆N
dally06464/+; lsd1 /+ (female)
dally01984/+
EY14216
dCoREST
/+; dally01984/+
k00237
mad
/+
EY14216
k00237
dCoREST
/+; mad
/+
k00237
∆N
mad
/+; lsd1 /+
KG00581
mad
/+
EY14216
KG00581
dCoREST
/+; mad
/+
KG00581
∆N
mad
/+; lsd1 /+
13
med /+
EY14216
13
dCoREST
/-; med /+
1
med /+
EY14216
1
dCoREST
/-; med /+
1
∆N
med / lsd1
1825
mirr /+
EY14216
1825
dCoREST
/-; mirr /+
1825
∆N
mirr /+; lsd1 /+
E(spl)mβ/+
∆N
lsd1 /E(spl)mβ
1
kn /+
EY14216
1
dCoREST
/-; kn /+
1
salm /+
EY14216
1
dCoREST
/-; salm /+
1
∆N
salm /+; lsd1 /+
1
px /+
EY14216
1
dCoREST
/-; px /+
1
∆N
px / +; lsd1 /+
ri-1
knirps /+
EY14216
ri-1
dCoREST
/-; kni /+
∆N
ri-1
lsd1 /knirps
KG08470
brk
/+
EY14216/
KG08470
dCoREST
brk
KG08470
∆N
brk
/+; lsd1 /+
MB04343
ara
/+
EY14216
MB04343
dCoREST
/+; ara
/+
biQD/+
EY14216
QD
dCoREST
/bi
∆N
QD
lsd1 /bi
MB00378
caup
/+
EY14216
MB00378
dCoREST
/+; caup
/+
∆N
MB00378
lsd1 /caup

No.
wings

%
Total
ectopic

%
Mult.
Ect

%
inc.
vein

98
32
100
102
104
90
102
138
22
20
104
187
44
117
121
102
112
84
96
54
28
104
60
126
65
80
36
60
169
68
70
94
44
30
95
146
207
100
52
130
100
36
100
44
76

0
53
12
25
35
0
1
5
23
0
5
27
86
26
80
8
4
4
20
0
93
8
43
1
51
1
8
7
11
47
11
0
34
30
20
12
21
8
79
2
0
11
12
86
26

0
0
1
2
0
0
0
1
0
0
0
0
5
0
8
0
0
0
1
0
7
0
10
0
15
0
6
3
1
32
0
0
7
0
5
1
0
2
27
3
0
3
2
52
2

0
9
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0

Genetic
interaction

Y
Y
Y
N
N
Y
N
Y
Y
Y
N
N
Y
Y
Y
Y
N
N
Y
N
Y
Y
N
N
Y
N
Y
Y
Y
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Signaling component
Dpp signaling (cont.)
schnurri

knirps-like

abrupt

No.
wings

%
Total
ectopic

%
Mult.
Ect

%
inc.
vein

Genetic
interaction

shn1/+
dCoREST EY14216/+; shn1/+
shn1/+; lsd1∆N/+
knrlMB05076/+
dCoREST EY14216/+; knrlMB05076/+
knrlMB05076/ lsd1∆N
ab1/+
dCoREST EY14216/+;ab1/+
ab1/+; lsd1∆N /+

156
150
126
192
76
80
148
99
100

0
0
0
23
4
66
2
39
1

0
0
0
1
0
13
0
2
0

0
6
3
0
0
0
0
0
0

0
Y1
Y2

cg1c1/+
dCoREST EY14216/+; cg1c1/+
cg1c1/+; lsd1∆N/+
tldB4/+
dCoREST EY14216/+; tldB4/+
cv-18/+
dCoREST EY14216/+; cv18/+
scw5/+
scw5/+; lsd1∆N/+ (female)
scw1/+
dCoREST EY14216/+;scw1/+
scwl1/+; lsd1∆N /+
tok1/+
dCoREST EY14216/+;scw5/+
tok1/ lsd1∆N

104
112
103
122
62
100
96
135
100
101
78
114
90
86
104

0
0
19
2
8
15
3
0
5
95
86
100
6
3
0

0
0
1
0
0
0
0
0
0
54
0
59
0
0
0

0
0
0
0
0
0
0
0
0
0
1
0
0
1
6

Genotype

Y
Y
Y
N

Crossvein signaling
combgap

tolloid
crossveinless
screw

tolkin

1

All wings examined have a curved/S-shaped PCV.
All wings examined have a curved/S-shaped PCV, but less severe than dCoRESTEY14216/+; shn1/+
siblings.

2

N
Y
N
Y (weak)
N
Y
N
N
N
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Figure 21 dlsd1∆N and dCoRESTEY14216 genetically interact with downstream Dpp
signaling components
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Figure 21 dlsd1∆N and dCoRESTEY14216 genetically interact with downstream Dpp
signaling components. (A-C) P(madKG00581) genetically interacts with dlsd1∆N and
dCoRESTEY14216. (A)Wings from P(madKG00581)/+ flies appear normal. (B)
P(madKG00581) /+; dlsd1∆N /+ transheterozygotes have ectopic vein material posterior to
L5. (C) Wings from dCoRESTEY14216 /+; P(madKG00581) /+ transheterozygotes have ectopic
vein material distal to the PCV and anterior to L5. (D-F) Med13 genetically interacts
with dlsd1∆N and dCoRESTEY14216. (D) Wings from Med13/+ flies appear normal. (E)
Med13 / dlsd1∆N transheterozygotes have ectopic vein material distal to the PCV. (F)
Wings from dCoRESTEY14216 /+; Med13/+ transheterozygotes have ectopic vein material
distal to the PCV. (G-I) mirr1825 genetically interacts with dlsd1∆N but not
dCoRESTEY14216. (G) Wings from mirr1825/+ flies appear normal. (H) mirr1825/dlsd1∆N
transheterozygotes have ectopic vein material distal to the PCV. (F) Wings from
dCoRESTEY14216 /+; mirr1825/+ appear normal. (J-L) araMB04323 genetically interacts with
dlsd1∆N and dCoRESTEY14216. (J)Wings from araMB04323 /+ heterozygotes appear normal.
(K) araMB04323/dlsd1∆N transheterozygotes have wings with ectopic vein material distal to
L5. (L) dCoRESTEY14216/+; araMB04323/+ transheterozygotes have wings with ectopic
vein material anterior to L2 and distal to the PCV. (M-O) shn1 genetically interacts with
dlsd1∆N and dCoRESTEY14216. (M) shn1 wings appear normal. (N) shn1 /+; dlsd1∆N /+
transheterozygotes have an incomplete PCV phenotype in a small percentage of wings.
All wings also have a slightly curved PCV. (O) dCoRESTEY14216 /+; shn1/+ have an
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incomplete PCV phenotype in a small percentage of wings. All wings also have a
slightly curved PCV.
4.20 Knockdown experiments suggest dLSD1/dCoREST negatively regulate Dpp
signaling components. My next goal was to determine if Dpp signaling is misregulated
when dLSD1 and/or dCoREST levels are decreased using the GAL4-UAS system to
drive UAS-RNAi constructs in wing imaginal discs. I performed immunohistochemical
analyses to detect phosphorylated Mothers Against Dpp (pMAD) in pupal wings.
pMAD is a downstream effector specific to activated Dpp signaling. The expression of
pMAD is localized to longitudinal proveins L1-L5, as well as the ACV and
PCV(Newfeld, Mehra et al. 1997). GawB69B, rho-lacZX81/+ control animals display the
expected pMAD pattern, with staining localized to the longitudinal and tranverse veins
(Figure 22B). UAS-Dicer/+; GawB69B, rho-lacZX81/Lsd1-IR wings also have a normal
pMAD staining pattern (Figure 22C). UAS-Dicer/+; Corest-IR/GawB69B, rho-lacZX81
wings display ectopic pMAD staining toward the distal margin (Figure 22D). Additional
knockdown of dLSD1, in UAS-Dicer/+; Corest-IR, GawB69B, rho-lacZX81/Lsd1-IR
wings shows enhancement of the ectopic pMAD expression, leading to ectopic pMAD
staining around the distal margin as well as the PCV (Figure 22E). These results
demonstrate that dCoREST is important for repressing Dpp signaling in intervein cells
and that dLSD1 may cooperate with dCoREST to repress vein cell differentiation.
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Figure 22: Knockdown of dlsd1and dCoREST leads to ectopic pMAD expression in
pupal wings

Figure 22: Knockdown of LSD1 corepressor components results in ectopic pMAD
expression (A) No primary antibody (-) control. (B) GawB69B, rho-lacZX81/+ control
animals. pMAD staining is confined to proveins L2-L5, ACV, PCV and the anterior
wing margin. (C) UAS-Dicer/+; Lsd1-IR/GawB69B, rho-lacZX81 pupal wings have
pMAD staining similar to control siblings, but may have a slightly thickened PCV
staining and a small increase at the distal edges of L3 and L4 (compare (B) and (C)). (D)
UAS-Dicer/+; Co-REST-IR/ GawB69B, rho-lacZX81 pupal wings display ectopic pMAD
staining at the distal tip of L4 (arrow) as well as a slightly thickened PCV. (E) UASDicer/+; CoREST-IR, GawB69B, rho-lacZX81/Lsd1-IR pupal wings have ectopic pMAD
staining distal to the PCV as well as around the distal wing margin (arrow)

Chapter 5
Discussion
In this dissertation, I have provided several lines of evidence suggesting the
mechanism of Brm complex-mediated gene repression is not only dependent upon a tight,
physical and genetic relationship between two core subunits, SNR1 and MOR, but also
on histone lysine demethylase enzymes. These enzymes can either recruit the BRM
complex to target genes or function as potential coregulators of Brm complex remodeling
activities. Further, I specifically identified Lysine Specific Demethylase-1 (LSD1) as a
potential cofactor which is critical for Brm complex-mediated gene repression. My
results from multiple biochemical as well as genetics-based approaches, which include
GST-pulldown, coimmunoprecipitation experiments, and genetic epistasis tests, clearly
demonstrate that a stable complex can form between dLSD1 and the Brm complex in
vivo. To the best of my knowledge, my analysis is the first to demonstrate that a stable
complex can form between dLSD1 and the Brm complex in vivo. In addition, my genetic
analyses further suggest that dLSD1 may specifically cooperate with a subtype of Brm
complexes, PBAP complexes, in the context of wing development.
Immunohistochemical analyses show that dLSD1 is expressed throughout the
pupal wing. However, my tissue and cell-type specific targeted knockdown experiments
suggest that the role of dLSD1 in repressing vein-promoting genes is likely limited to
intervein territories. Knockdown using wing-specific drivers resulted in the formation
122
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of ectopic vein material in territories that should only contain intervein cells. If dLSD1
had a role in promoting vein cell differentiation, then loss of dLSD1 throughout the wing
would result in incomplete vein phenotypes, which were not observed. This suggests
that while dLSD1 is expressed throughout the entire pupal wing, its activity appears
limited to restricting vein cell differentiation in intervein cells.
The ectopic vein phenotypes associated with loss of dLSD1 are similar to those
observed with knockdown of dCoREST, a cofactor required for recruitment of dLSD1 to
methylated lysine substrates. It has been demonstrated that dLSD1/dCoREST can form a
complex with either TTK69 or TTK88 (Dallman, Allopenna et al. 2004). My
overexpression analyses suggest that TTK69, but not TTK88, function to negatively
regulate vein cell development, since overexpression of TTK69 led to incomplete veins,
whereas overexpression of TTK88 lead to ectopic veins. Therefore, I predict that a
dLSD1/dCoREST/TTK69 form a complex in the developing wing tissue to negatively
regulates the highly conserved Dpp signaling pathway in intervein cells.
5.1 MOR has an important role in regulating Brm complex stability and regulatory
activities
A core complex can form between 3 subunits, BRM, MOR, and SNR1 (Phelan, Sif et al.
1999). MOR is critical for core complex formation, as depletion of MOR by RNAi in
cell culture analyses leads to loss of SNR1 and BRM protein levels, as tested with
Western Blot analysis (Curtis et al. 2010, (Moshkin, Mohrmann et al. 2007). MOR likely
serves as a scaffolding protein, since physical associations were observed between SNR1MOR and MOR-BRM. Two independent domains of MOR, the SWIRM and SANT
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domains respectively, are critical for the binding interaction (Crosby, Miller et al. 1999;
Phelan, Sif et al. 1999; Moshkin, Mohrmann et al. 2007). My work suggests that the Cterminal portion of SNR1, containing the Repeat II region and Coiled-coil of SNR1
mediates the physical SNR1-MOR SWIRM relationship. I show that the Coiled-coil
structure is not essential for the interaction, as a point mutant predicted to prevent Coiledcoil formation (SNR1I350P) strongly interacted with the MOR SWIRM. However, it is
possible that the amino acid sequence that makes up the coiled-coil, rather than the
formation of a coiled-coil structure itself, contribute to the SNR1-MOR interaction since
no structural analysis of the SNR1 protein or its orthologs has been performed. Genetic
epistasis experiments suggest an important functional relationship between SNR1 and
MOR. I observed a strong, allele specific, genetic interaction between the dominant
negative snr1E1 allele and several loss of function mor alleles, suggesting an important
relationship between the two subunits. Moreover, the contribution of SNR1 regulatory
function on Brm complex chromatin remodeling activities may depend on crosstalk
through MOR, where MOR serves as a scaffolding protein, since no direct physical
contacts between SNR1 and the BRM subunit have been observed.
In order to fully understand if SNR1 regulatory activities on Brm complex
chromatin remodeling function are mediated by physical association with MOR,
structural analysis of the SNR1 tertiary structure is required. The Repeat Regions are
required for mediating protein-protein interactions between the SNR1 homolog, INI1,
and other factors not present in the Brm complex, such as EBNA2, MLL, c-Myc,
BRCA1, p53, and RB (Wu, Kalpana et al. 1996; Rozenblatt-Rosen, Rozovskaia et al.
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1998; Cheng, Davies et al. 1999; Bochar, Wang et al. 2000; Lee, Kim et al. 2002;
Versteege, Medjkane et al. 2002; Kato, Honma et al. 2007). The numerous physical
associations between the Repeat Regions and other proteins imply that this region is
exposed on the outer surface of the protein. Though no protein-protein interactions have
been observed between the coiled-coil region of SNR1 and other proteins, my results do
not eliminate the possibility that Repeat Region II can physically associate with the MOR
SWIRM domain.
Characterization of the MOR SWIRM domain has given some insight into which
residues of MOR physically associate with SNR1. In vitro structural analyses of the
SWIRM domain from the murine MOR homolog, SRG3, demonstrated that the last six
C-terminal most amino acids of the SWIRM are necessary for the interaction with the
SNR1 homolog, SNF5 (Sohn, Lee et al. 2007). Structural analyses suggest that these
amino acids are located on solvent exposed patches, likely important for mediating
protein-protein interactions (Da, Lenkart et al. 2006). My site-directed mutagenesis
experiments suggest that the structure of the groove is not important for the SNR1-MOR
association in vitro, although structural analyses must be performed to verify this
prediction.
5.2 Deficiency screen identifies histone demethylase enzymes as potential
coregulators of Brm complex activities
A large scale chromosomal deficiency screen allowed us to identify histone lysine
demethylase enzymes as novel coregulators of the Brm complex in controlling gene
expression. Previous screens looking for dominant genetic modifiers of a brm dominant
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negative allele, brmK804R, did not uncover mutations in histone-modifying families, such
as acetyltransferases, deacetylases, and methyltransferases (Armstrong, Sperling et al.
2005). However, the wing patterning defect associated with snr1E1 is sensitive, allowing
me to observe subtle changes in remodeling activities, and identify a family of epigenetic
modifiers as potential Brm co-regulators. Specifically, I found that six independent
mutations in predicted demethylase genes genetically interacted with snr1E1, suggesting
that demethylases may be potential cofactors of Brm complex remodeling activities. I
found no correlation between the predicted demethylase lysine substrate and
enhancement/suppression of the snr1E1 phenotype. This is not surprising, since a high
degree of functional redundancy exists among demethylase enzymes (Klose and Zhang
2007). It is likely that demethylase enzymes regulate a different set of target genes. This
is supported by experimental evidence showing that knockdown experiments of
individual demethylases, for example dLSD1, in cell culture often showed little or no
change in global methylation status, though significant changes were observed on a genespecific level (Di Stefano, Ji et al. 2007). Independent loss of function mutations in two
JARID family members, lid or CG3654, resulted in an opposite genetic interaction with
snr1E1. I observed that a loss of function mutation in lid, (lid2) dominantly suppressed,
whereas a loss of function mutation in CG3654 (CG3654EY02717) enhanced the ectopic
vein phenotype associated with snr1E1. LID is an H3K4me3/me2 specific demethylase
(Secombe, Li et al. 2007; Lloret-Llinares, Carre et al. 2008). CG3654 is predicted to
have the same substrate specificity, though overexpression analyses in cell culture
experiments showed no global increase in H3K4me3/2 (Lloret-Llinares, Carre et al.
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2008). The observed opposite genetic interaction with snr1E1 is likely because LID and
CG3654 regulate different target genes during wing development.
The cell-fate decision to become vein or intervein is largely based on cell-type
specific expression of transcription factors. In vein cells, transcription factors with gene
targets that promote vein development are highly expressed, whereas those with gene
targets that block vein fate are repressed. In intervein cells, the opposite is observed, with
heightened expression intervein-promoting factors and decreased expression of vein
promoting factors. The Brm complex has an important role in development of both cell
fates, serving a positive role to promote vein development in vein cells, and repress vein
development in intervein cells (Marenda, Zraly et al. 2004). The opposite genetic
interaction phenotypes are easily explained if the Brm complex is coordinating with the
each specific demethylase to regulate different target genes. Loss of function mutations
in vein promoting genes, such as Egfr, suppressed the snr1E1 phenotype (Marenda, Zraly
et al. 2004). Though EGFR and LID have very different known roles, one is a receptor
and one a demethylase enzyme, both may function to promote vein development. My
results suggest that LID may have a similar function as EGFR to activate genes important
for vein development, so that a loss of function mutation in lid results in a decrease in
vein promoting genes, and results in suppression of the snr1E1 ectopic vein phenotype.
Enhancement of the snr1E1 phenotype by CG3654EY02717 can be explained if CG3654
promotes activation of genes required to block vein differentiation, just as loss of
function mutations in vein-inhibiting factors, such as the transctription factor, net,
enhanced the snr1E1 phenotype (Marenda, Zraly et al. 2004)

128
My candidate genetic screen results suggest that histone lysine demethylase
enzymes are likely cofactors of Brm chromatin remodeling activity. However, it is
highly unlikely that physical associations are made between the complex and all six
demethylases. I cannot eliminate the possibility that the Brm complex and demethylase
enzymes are independently regulating genes involved in wing patterning. However, I did
observe a direct physical association between the Brm complex and LSD1 in
coimmunoprecipitation and GST-pulldown experiments, implying that LSD1 is a
potential cofactor of Brm complex remodeling activities (Curtis et. al, 2010 in
preparation).
5.3 dLSD1 may be a cofactor specific to the PBAP family of Brm complexes
My genetic epistasis experiments demonstrated an important in vivo functional
relationship between LSD1 and the core subunits of the Brm complex, SNR1, MOR, and
BRM. Brm complexes can be subdivided into two groups: PBAP complexes contain
BAP170 and POLYBROMO, whereas BAP complexes contain OSA. These complexes
can regulate target genes in a synergistic, antagonistic, or independent manner
(Mohrmann, Langenberg et al. 2004; Moshkin, Mohrmann et al. 2007). BAP and PBAP
complexes likely have differential regulatory functions, since they have distinct, but
overlapping, localization patterns on larval salivary gland polytene chromosomes
(Mohrmann, Langenberg et al. 2004) and targeted knockdown of OSA, POLYBROMO,
or BAP180 using RNAi in cultured Drosophila cells (S2), leads to differential gene
expression profiles on whole genome arrays (Moshkin, Mohrmann et al. 2007). OSA can
target the Brm complex to DNA, in a non-sequence specific manner and can promote
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transcriptional repression of genes regulated by Wnt/Wingless signaling (Collins,
Furukawa et al. 1999; Collins and Treisman 2000). Microarray analyses of
polybromo/bap180, bap170 double mutants demonstrated that PBAP complexes may be
involved in gene activation as well as repression (Carrera, Zavadil et al. 2008). PBAP
complexes also appear to have an important role in wing development, though it is not
known which pathways are regulated (Moshkin, Mohrmann et al. 2007). My genetic
epistasis experiments suggest that LSD1 cooperates with PBAP, but not BAP containing
complexes. These results suggest that the physical association I observed between LSD1
and Brm complex may be limited to PBAP complexes, and provide another mechanism
for selective target gene recruitment and regulation by Brm remodeling complexes.
Further analyses, such as GST-pulldown and coimmunoprecipitation experiments using
PBAP specific antibodies need to be performed to address this possibility.
5.4 dLSD1 and dCoREST have a cell-type specific role to repress vein-cell
differentiation
In this study, I provided several lines of evidence suggesting and important role
for dLSD1 and the cofactor, dCoREST, in regulating wing development. Each wing has
five longitudinal veins and two transverse veins. The pattern, size, shape, and placement
of the veins is a highly regulated process and requires collective signaling by five highly
conserved pathways, involving the proteins Hh, Dpp, N, Wg, and Egfr. Misregulation of
these pathways can lead to specific developmental defects, including incomplete veins,
ectopic veins, misshaped wings, or changes in the space between the veins. The role of
each pathway during wing development has been described largely based on genetic
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epistasis, somatic clones, and tissue-specific knockdown experiments and demonstrate
Egfr and Dpp signaling both have important roles in vein-cell initiation and maintenance
(reviewed in (Blair 2007). Each pathway has a unique contribution to wing development,
but a high degree of crosstalk between the pathways has been observed (Sotillos and De
Celis 2005). For example, KNIRPS/KNIRPS-RELATED (KNI/KNRL) are transcription
factors expressed in L2 proveins in response to dose-dependent Dpp signaling. One
main KNI/KNRL target is rhomboid. Rhomboid is required for processing of the main
Egfr ligand, Spitz, therefore linking Egfr and Dpp signaling.
Ectopic vein development within intervein tissue can result from two different
possibilities: 1) The loss of a factor necessary to block vein cell differentiation, or 2) the
gain of a factor that promotes vein cell differentiation. My knockdown experiments
suggest dLSD1/dCoREST function through the first mechanism. Loss of
dLSD1/dCoREST throughout the entire developing wing imaginal disc resulted in the
development of vein material in intervein tissue, but no changes in vein morphology were
observed. If dLSD1/dCoREST normally functioned to promote vein development, then
loss throughout the entire wing would have led to a loss of vein phenotype.

5.5 dLSD1 regulates genes important for terminal differentiation
Several lines of evidence suggest that dLSD1 regulates gene transcription in a
cell-type or stage dependent manner. The effect of homozygous loss of dLSD1 on
transcriptional regulation of known target genes, including the Sodium Channel and
Nicotinic Acetlycholine Receptor –β is minimal in embryos and larvae, but significant in
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pupae (Di Stefano, Ji et al. 2007). This implies that LSD1 has an important role in
regulating gene transcription during later developmental stages. This stage-dependent
requirement appears to be conserved, as the conditional knock-out of LSD1 in the
developing mouse pituiitary gland causes little or no morphological defects early in
pituitary development (E9-9.5), but significantly alters cell-fate determination choices
during later stages (E17.5). Moreover, LSD1 mediates both gene activation and gene
repression of different target genes by associating with alternate multisubunit complexes
(Wang, Scully et al. 2007).
My knockdown and genetic epistasis experiments further support the idea that
dLSD1 is important for regulating terminal differentiation, since patterning phenotypes
are similar to those observed with defects in Dpp and Egfr signaling, the pathways active
during pupal development, rather than those observed with defects in Hh signaling, an
early pathway component. During wing development, the signals promoting vein cell
fate must be confined to vein territories, or ectopic veins will develop in intervein
territories. Activated Dpp signaling is confined to vein territories largely by the
overexpression of THICKVEINS (TKV), a member of the TGFβ superfamily, in
intervein boundary cells. TKV binds the DPP morphogen and sequesters spreading over
adjacent intervein cells. When TKV is downregulated, the DPP morphogen can spread
into intervein territories, and induce improper differentiation into vein-fate by binding
and activating the TKV receptor. Loss of function mutations in Dpp signaling
components are correlated with loss of vein phenotypes, whereas overexpression of Dpp
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signaling components results in ectopic vein development (Spencer, Hoffmann et al.
1982; Segal and Gelbart 1985; Singer, Penton et al. 1997).
5.6 dLSD1/dCoREST may cooperate with TTK69 to repress vein cell development
In Drosophila, immunoprecipitation experiments suggest a complex forms
between the HDAC1/2 class protein RPD3, dLSD1, dCoREST, and two TTK splice
variants TTK88 or TTK69 (Dallman, Allopenna et al. 2004). Complexes containing
dCoREST/TTK69 or dCoREST/TTK88 are found to independenly colocalize on polytene
salivary glands, suggesting that these complexes regulate different target genes (Dallman,
Allopenna et al. 2004). I sought to identify which of these complexes are involved in
wing development by performing tissue specific overexpression experiments. I found
that overexpression of TTK69 in intervein cells resulted in a loss of vein phenotype,
whereas overexpression of TTK88 in intervein cells resulted in ectopic vein development.
I found that knockdown of dLSD1 and/or dCoREST results in the development of ectopic
veins, a phenotype opposite of TTK69 overexpression, suggesting dLSD1, dCoREST,
and TTK69 may have similar roles to repress vein cell differentiation in intervein
territories. Since a complex a dLSD1/dCoREST/TTK69 complex has been observed
(Dallman, Allopenna et al. 2004), I propose that this complex is involved in regulating
the conserved siganaling pathways required for vein cell development. I do not predict
the dLSD1/dCoREST/TTK88 complex is involved in wing development, since the
knockdown phenotypes with dCoREST and dLSD1 are similar to overexpression of
TTK88. This suggests that dCoREST/dLSD1 may function independently of TTK88
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during wing development, since the role of dCoREST/dLSD1 appears to be repressing
vein cell differentiation, and that of TTK88 appears to promote vein cell differentiation.
It has been suggested that TTK and REST are functional homologs since
orthologs of tramtrack only exist in invertebrates, whereas orthologs of REST only exist
in vertebrates (Dallman, Allopenna et al. 2004). Evidence from mammalian work on the
Brm complex homolog, Brg1, shows that mammalian LSD1 (mLSD1) can not only
physically associate with the Brg1 complex, but that remodeling activities are essential
for proper recruitement of the larger LSD1/CoREST, REST, Brg1 complex to appropriate
promoter sequences (Ooi, Belyaev et al. 2006). I propose a model where a supercomplex
containing the Brm remodeling complex, dLSD1/dCoREST/TTK69 cooperate to regulate
genes essential for wing development. Like its functional ortholog, REST, TTK69 is a
transcription factor that can recognize and bind to a specific DNA RE-1consensus
sequence (CCAGGACG), resulting in gene transcription (Dallman, Allopenna et al.
2004). GST-pulldown and co-immunoprecipitation experiments using whole embryo
Drosophila extracts demonstrated that the Brm complex can physically associate with
dLSD1 in vivo (Curtis et. al, submitted 2010). These same experiments need to be
perfomed using antibodies specific to dCoREST, TTK69, or TTK88 to determine if the
Brm complex can physically associate with dCoREST, TTK69, or TTK88. In order to
determine if this super complex is recruited to RE-1 binding sites, chromatin
immunoprecipitation experiments need to be performed using antibodies specific to
dLSD1/dCoREST/BRM/TTK69/TTK88 and dissected pupal wings, since different
complexes likely form in different tissues
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My results suggest dLSD1/dCoREST negatively regulate Dpp signaling. Genetic
epistasis experiments demonstrated that dlsd1∆N and dCoRESTEY14216 genetically
interacted with upstream (ex. dpp, tkv, sax) and downstream (ex. mad, med, ara, caup,
shn) Dpp signaling components. My immunohistochemical analyses demonstrated that
phosphorylated MAD, a downstream signaling protein specific to the Dpp pathway, is
misexpressed when dlsd1 or dCoREST were knocked down, further supporting a role for
dLSD1/dCoREST in regulating the Dpp pathway. Since I observed genetic interaction
with upstream and downstream signaling factors, it is most likely that dLSD1/dCoREST
are required for upstream dpp signaling.
I predict the most likely upstream Dpp signaling target of dLSD1/dCoREST
regulation is the thickveins gene for three reasons. First, genetic interactions were
observed between loss of function dLsd1/dCoREST mutations and almost all loss of
function mutations in Dpp signaling components, indicating that dLSD1/dCoREST likely
regulate an upstream signaling factor. Second, tissue-specific knockdown of
dlsd1/dCoREST leads to the development of ectopic veins, similar to phenotypes
observed with loss of TKV (Ruberte, Marty et al. 1995). Third, my overexpression
experiments suggest that TTK69, but not TTK88, likely has a similar role as dLSD1 and
dCoREST to negatively regulate vein cell differentiation. Therefore, I predict a complex
exists that contains dLSD1/dCoREST/TTK69 in the developing pupal wing. The
thickveins gene contains the TTK69 specific RE-1 consensus DNA-binding sequence (my
unpublished observation), making it a candidate target gene for
dLSD1/dCoREST/TTK69 –mediated gene regulation.

Chapter 6
Conclusions and Remaining Questions
In this work, I have provided several lines of evidence suggesting an important
role for the dLSD1 corepressor complex in tissue development and patterning. My work
supports the following model to describe how dLSD1/dCoREST contributes to wing
development.
Normal dCoREST/dLSD1: 1. The Brm chromatin remodeling complex utilizes
the energy of ATP to relax histone-DNA contacts and expose the RE-1consensus
sequence in the thickveins promoter. 2. In boundary intervein cells, TTK69 recognizes
and binds to the RE-1 consensus sequence, recruiting the TTK69/dLSD1/dCoREST/Brm
super complex. 3. dCoREST recognizes and presents H3K9me/2 substrates to dLSD1.
4. dLSD1 demethylates H3K9 residues, resulting in relaxed chromatin status and
consequent transcription of tkv. 5. TKV expression in intervein boundary cells
sequesters the Dpp ligand which is expressed at high level in vein cells, and prevents Dpp
spreading into intervein territories. 6. Normal vein pattern develops. (Figure 23A)
Mutant dLSD1/dCoREST: 1. The Brm chromatin remodeling complex utilizes
the energy of ATP to relax histone-DNA contacts and expose the RE-1consensus
sequence in the thickveins promoter. 2. In boundary intervein cells, TTK69 recognizes
135

136

and binds to the RE-1 consensus sequence, recruiting the TTK69/dLSD1/dCoREST/Brm
super complex. 3. dCoREST normally recognizes and presents H3K9me/2 substrates to
dLSD1. If dCoREST is mutated or knockdown, less H3K9me/2 substrate is presented to
dLSD1 and therefore less H3K9 substrates are demethylated.

4. A decrease in H3K9

demethylation will result in decreased chromatin relaxation and decreased tkv
transcription. The same effect will occur if dLSD1 is mutated or knocked down. 5.
TKV expression in intervein boundary cells normally sequesters the Dpp ligand which is
expressed at high level in vein cells, and prevents Dpp spreading into intervein territories.
If tkv transcription is decreased, then less TKV can bind and sequester the Dpp ligand.
Dpp will spread into intervein territories and induce vein-cell differentiation. 6. Ectopic
veins develop. (Figure 23B)
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Figures 23: Models for the role of dLSD1 in normal wing development (A) and
when dlsd1/dCoREST are mutated/ knocked-down (B)

A. Normal wing development
LSD1 represses vein development by activating thickveins
Provein
Dpp binds tkv

Intervein Boundary
dLSD1+
dCoREST

Phosphorylation
of MAD

Activation
of downstream
target genes

Intervein

No Dpp signaling
thickveins
upregulated
Intervein cell
fate

Dpp signal Activated
Dpp ligand produced

Dpp ligand
sequestered
Vein fate
Legend:
Dpp ligand:

TKV receptor:

Dpp bound to TKV:
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B. Ectopic vein Development
Mutant dLSD1/dCoREST causes ectopic vein development by decreased tkv
transctption

Provein
Dpp binds tkv

Intervein Boundary
dLSD1+
dCoREST

Phosphorylation
of MAD

Phosphorylation
of MAD
Activation
of downstream
target genes
Dpp signal
Activated/
Dpp ligand produced

Thickveins
transcrtiption
decreased

Activation
of downstream
target genes
Ectopic
Dpp signaling

Dpp signal
not completely
sequestered
Vein fate

Vein fate
Legend:
Dpp ligand:

Intervein

TKV receptor:

Dpp bound to TKV:

Figure 23: Models to demonstrate how loss of dLSD1 and/or dCoREST may cause
the development of ectopic veins. (A) Normal wing development. The three main
types of cells present in the developing Drosphila wing, provein, intervein boundary, and
intervein, are indicated. In the developing proveins (left column) Dpp signaling is active,
resulting in the release of Dpp ligand. In the intervein boundary cells (center column),
dLSD1 and dCoREST regulate the transcription of thickveins (tkv). TKV binds and
sequesters the Dpp ligand. In intervein cells (right column), Dpp signaling is not active,
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since TKV sequestered the Dpp ligand to intervein boundary cells. No active Dpp
signaling results in the differentiation of intervein cells. (B) Ectopic vein development.
In the developing proveins, Dpp signaling is active, resulting in the release of Dpp ligand
into the cytosol (left column). When dLSD1/dCoREST are knocked-down (as indicated
by the red X), transcription of tkv is decreased. Decreased dLSD1/dCoREST results in
decreased TKV receptor expression and less sequesteration of the Dpp ligand (center
column). Spreading of Dpp ligand into intervein territories results in the development of
ectopic vein cell differentiation by activation of the Dpp signaling pathway (right
column).
Several important conclusions can be drawn from my work. I identified a family
of epigenetic modifying enzymes, histone lysine demethylases, which potentially
cooperate with the Brm chromatin remodeling complex. Specifically, I demonstrated an
important genetic interaction between multiple Brm complex subunits and dLSD1. I
found that a subtype of Brm complex, the PBAP complex, genetically interacts, while the
BAP complex does not. I further demonstrated using immunohistochemisty, in vivo
reporter gene assays, and genetic epistasis experiments, that the conserved signaling
pathway regulated by dLSD1is likely the Dpp signaling cascade.
In order to validate my proposed model, several important experiments must be
performed. To determine whether dLSD1/dCoREST physically associate with either
BAP, PBAP, or both BAP/PBAP complexes, coimmunoprecipitation and GST-pulldown
experiments must be performed using pupal wing tissue and antibodies specific to the
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subunits that make these complexes unique (OSA for BAP complexes, POLYBROMO,
SAYP, BAP180 for PBAP complexes).
Three main possibilites exist to explain how the Brm complex and dLSD1
corepressor complex may be functioning to regulate normal tissue patterning and
development. 1. It is possible that the Brm complex and the dLSD1 corepressor
complex are regulating the same signaling pathyway, but different genes. 2. The Brm
complex and dLSD1 corepressor complex are regulating the same genes, but at different
times. 3. The Brm complex and dLSD1 corepressor complex directly contribute to gene
regulation by acting on the same targets at the same time in development. In order to
address these possibilities, chromatin immunoprecipitation experiments must be
performed, using pupal wing extracts. Since I predict that the Brm complex and the
dLSD1 corepressor complex are regulating tkv transcription, ChIP experiments looking
for binding of dCoREST,TTK69, dLSD1, BRM, OSA, and PBAP to the RE-1 consensus
region should be completed. This experiment will determine whether the dLSD1
corepressor complex and the Brm complex are binding the tkv RE-1 consensus at the
same point in development.
It was previously demonstrated that the Brm complex regulates tkv transcription
(Marenda, Zraly et al. 2004).

My model also suggests that the dLSD1 corepressor

complex functions to positively regulate tkv expression in boundary intervein cells. This
can be addressed by performing in vivo reporter gene assays using a tkv-lacZ enhancer
trap line to test whether transcription of tkv is downregulated in dLSD1 and/or dCoREST
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knockdown lines, as well as TTK69 overexpression lines. If my model is correct, this
experiment should result in a decrease in lacZ expression in pupal wings. To determine if
TKV protein levels are decreased in dLSD1 and/or dCoREST knockdown lines, as well
as TTK69 overexpression lines, immunohistochemical analyses using antibodies specific
to TKV can be performed. However, at this time no TKV antibodies are available to
detect endogenous TKV in immunohistochemical analyses, as I made several attempts to
perform this experiment using antibodies that work well in Western Blot and
immunoprecipitation experiments.
My dissertation project has provided the framework for understanding how
chromatin remodeling complexes and epigenetic modifying enzymes collaborate to
regulate target genes. My work has broader applications in many fields including
development, gene expression, and cell cycle regulation. Work in Drosophila and
mammals have clearly demonstrated that dLSD1/mLSD1 are found in several different
complexes. It is important to understand how these complexes differentially regulate
target genes so that clinical and translational scientists can design small molecule
inhibitors and other drugs for disease treatment.
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